WO2021145740A1 - Group health index evaluation method and computer program for executing same - Google Patents

Group health index evaluation method and computer program for executing same Download PDF

Info

Publication number
WO2021145740A1
WO2021145740A1 PCT/KR2021/000637 KR2021000637W WO2021145740A1 WO 2021145740 A1 WO2021145740 A1 WO 2021145740A1 KR 2021000637 W KR2021000637 W KR 2021000637W WO 2021145740 A1 WO2021145740 A1 WO 2021145740A1
Authority
WO
WIPO (PCT)
Prior art keywords
factor
major disease
productivity loss
loss
productivity
Prior art date
Application number
PCT/KR2021/000637
Other languages
French (fr)
Korean (ko)
Inventor
김찬원
홍성우
오형석
김형준
이진명
고유상
김창욱
이승철
조성제
오태준
Original Assignee
(의) 삼성의료재단
주식회사 삼성경제연구소
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (의) 삼성의료재단, 주식회사 삼성경제연구소 filed Critical (의) 삼성의료재단
Publication of WO2021145740A1 publication Critical patent/WO2021145740A1/en

Links

Images

Classifications

    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00Administration; Management
    • G06Q10/10Office automation; Time management
    • G06Q10/105Human resources
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00Administration; Management
    • G06Q10/06Resources, workflows, human or project management; Enterprise or organisation planning; Enterprise or organisation modelling
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00Administration; Management
    • G06Q10/06Resources, workflows, human or project management; Enterprise or organisation planning; Enterprise or organisation modelling
    • G06Q10/063Operations research, analysis or management
    • G06Q10/0631Resource planning, allocation, distributing or scheduling for enterprises or organisations
    • G06Q10/06311Scheduling, planning or task assignment for a person or group
    • G06Q10/063114Status monitoring or status determination for a person or group
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00Administration; Management
    • G06Q10/06Resources, workflows, human or project management; Enterprise or organisation planning; Enterprise or organisation modelling
    • G06Q10/063Operations research, analysis or management
    • G06Q10/0637Strategic management or analysis, e.g. setting a goal or target of an organisation; Planning actions based on goals; Analysis or evaluation of effectiveness of goals
    • G06Q10/06375Prediction of business process outcome or impact based on a proposed change
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00Administration; Management
    • G06Q10/06Resources, workflows, human or project management; Enterprise or organisation planning; Enterprise or organisation modelling
    • G06Q10/067Enterprise or organisation modelling
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00Administration; Management
    • G06Q10/10Office automation; Time management
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients

Definitions

  • Embodiments of the present invention relate to a method for evaluating a tissue health index and a computer program for executing the same.
  • Health management refers to a management method that promotes organizational performance improvement by creating a work environment that can motivate healthy work performance.
  • Embodiments of the present invention by deriving a productivity loss prediction model using a database including factor control research information and questionnaire data of members, a method for evaluating the organizational health index for predicting the productivity loss of the organization and a computer program executing the same would like to provide
  • An embodiment of the present invention is a tissue health index evaluation method for evaluating the health index of an organization according to the health status of a member, wherein the member's said member with respect to a plurality of major disease factors preset from a database including factor control study information Receiving the prevalence information for each major disease factor, receiving the time and attendance information of the member according to each of the major disease factors, and the loss of productivity of the tissue using the prevalence information for each major disease factor and the member's time and attendance information It provides a method for evaluating the tissue health index, including the step of deriving a productivity loss predictive model for predicting.
  • the attendance information of the member according to each of the major disease factors may be provided by using the questionnaire data of the member.
  • the step of deriving the productivity loss predictive model comprises the steps of calculating the productivity loss effect for each major disease factor from the questionnaire data of the member, and the prevalence information for each major disease factor and the It may include deriving a productivity loss predictive model for predicting the productivity loss by using the productivity loss effect for each major disease factor.
  • the questionnaire data is data on Absenteeism and Presenteeism of a member due to the major disease factor
  • the Absenteeism is the member due to the major disease factor. of absenteeism or early departure, and the presentism may be the degree of loss of productivity of members due to the major disease factor.
  • the productivity loss effect by each major disease factor and the productivity loss degree may be calculated by the following Equations (1) and (2), respectively.
  • LPAi is (absentism time for a first preset period due to major disease factor i)/(total working hours during said first period), and LPPi is said first time period due to major disease factor i
  • the degree of presentism during the period, and pim is the prevalence of major disease factor i in tissue m.
  • the step of deriving the productivity loss prediction model comprises setting the degree of influence on productivity loss for each major disease factor as an absolute influence on the degree of productivity loss of the major disease factor, and
  • the method may further include setting the product of the ratio of the effect of the productivity loss for each disease factor and the ratio of the number of members having the major disease factor to the total number of members of the tissue as the relative influence of the major disease factor on the productivity loss.
  • the step of deriving the productivity loss predictive model sets the absolute productivity loss degree of the organization by standardizing the productivity loss degree on the basis of a case in which no productivity loss occurs
  • the method may further include setting the relative productivity loss of the organization by standardizing the productivity loss on the basis of the maximum and minimum values of the productivity loss of the entire organization in the database including the factor control study information.
  • the step of deriving the productivity loss prediction model comprises calculating the total productivity loss, the total production time loss, and the total production wage loss by the following Equations (3) to (5), respectively. It may include further steps.
  • Tm is the average working hours of organization m
  • Wm is the average wage of organization m
  • the major disease factors may include cardiovascular disease, allergic disease, respiratory disease, digestive disease, depressive disease, and sleep disease.
  • the step of deriving the productivity loss predictive model includes deriving all pathways in which the onset risk factor affects the productivity loss, and the onset risk factor is determined according to the number of the pathways. By calculating the weight of the influence on the productivity loss, it is possible to derive a predictive model of the productivity loss.
  • the step of deriving the productivity loss predictive model includes calculating the sum total of changes in the net incidence of the major disease factors due to the onset risk factors, the prevalence by each major disease factor and the Calculating the effect of the onset risk factor on the prevalence of the major disease factor from the sum of changes in net incidence, and the effect of the onset risk factor on productivity loss from the effect of the onset risk factor on the prevalence of the major disease factor It may include calculating the weight of the disease risk factor and calculating the disease risk index from the weight of the effect on the productivity loss.
  • the sum of changes in the net incidence of the major disease factors due to the onset risk factors, the effect of the onset risk factors on the prevalence of the major disease factors, and the onset risk factors affect the productivity loss
  • the weight of the influence and the disease risk index can be calculated by the following formulas (6) to (9).
  • i is a major disease factor
  • j is an onset risk factor
  • n ji is the net incidence of the major disease factor i by the onset risk factor j
  • p j is the prevalence of the onset risk factor j
  • pi is the prevalence of the major disease factor i.
  • the odds ratio is calculated from a database including the factor control study information.
  • the step of deriving the productivity loss predictive model comprises setting the absolute risk index of the tissue by standardizing the onset risk index on the basis of a case in which no productivity loss occurs,
  • the method may further include setting the relative incidence risk index of the tissue by standardizing the onset risk index based on the maximum and minimum values of the onset risk index of the entire organization in the database including the factor control study information.
  • the onset risk factor includes a prior disease factor affecting the main disease factor, and a health-influencing factor affecting the main disease factor or the antecedent disease factor, and the onset risk
  • the index may include a prior disease risk index due to the preceding disease factor and a health impact risk index due to the health influence factor.
  • the major disease factors include cardiovascular diseases, allergic diseases, respiratory diseases, digestive diseases, depressive diseases and sleep diseases, and the preceding disease factors are diabetes, hypertension, obesity, and high cholesterol.
  • the health-influencing factors may include smoking, lack of exercise, general stress, job stress, and drinking.
  • An embodiment of the present invention provides a computer program stored in a medium to execute any one of the methods described above using a computer.
  • the tissue health index evaluation method and the computer program executing the same according to embodiments of the present invention, the member's prevalence information for each major disease factor with respect to a plurality of major disease factors set in advance from a database including factor control study information And, by receiving the time and attendance information of the member according to each of the major disease factors, and using the prevalence information for each major disease factor and the time and attendance information of the member, a productivity loss prediction model for predicting the productivity loss of the tissue is derived. can do.
  • the organizational health index evaluation method and the computer program executing the same use both the data that can objectively determine the health status of the member and the data that can identify the member's working environment as a predictive model for productivity loss By deriving this, it is possible to calculate the organizational health index that can organically understand the relationship between the health status of members and the loss of productivity of the organization, and through this, it is possible to identify the current level of productivity loss of the organization and predict the risk of potential loss of productivity there is.
  • FIG. 1 is a flowchart schematically illustrating a method for evaluating a tissue health index according to an embodiment of the present invention.
  • FIG. 3 is a diagram illustrating an example of the factor control study information of FIG. 1 , wherein FIG. 3 (a) shows information on population composition by year, and FIG. 3 (b) shows information about a disease to be investigated by year.
  • FIG. 4 is a flowchart for explaining in more detail the step of deriving the productivity loss prediction model of FIG. 1 .
  • Figure 5 is a view showing an example of applying the tissue health index evaluation method according to an embodiment of the present invention
  • Figure 5 (a) is an example of calculating the productivity loss of the organization
  • Figure 5 (b) is the main This is an example of calculating the absolute influence and the relative influence on productivity loss by disease factor.
  • FIG. 6 is a flowchart schematically illustrating a method for evaluating a tissue health index according to another embodiment of the present invention.
  • FIG. 7 is a flowchart illustrating the productivity loss prediction model of FIG. 6 .
  • FIG. 10 is a diagram illustrating an example of an odds ratio used in the step of deriving the productivity loss prediction model of FIG. 6 .
  • a film, region, or component when a film, region, or component is connected, other films, regions, and components are interposed between the films, regions, and components as well as when the films, regions, and components are directly connected. It also includes cases where it is indirectly connected. For example, in this specification, when it is said that a film, a region, a component, etc. are electrically connected, not only the case where the film, a region, a component, etc. are directly electrically connected, but also other films, regions, components, etc. Indirect electrical connection is also included.
  • FIGS. 1 to 5 a method for evaluating a tissue health index according to an embodiment of the present invention will be described with reference to FIGS. 1 to 5 .
  • FIG. 1 is a flowchart for schematically explaining a method for evaluating a tissue health index according to an embodiment of the present invention
  • FIG. 2 is a graph related to the health status of a member and a loss of organizational productivity
  • FIG. 3 is a factor contrast of FIG.
  • FIG. 3(a) shows information on population composition by year
  • FIG. 3(b) shows information on a disease to be investigated by year.
  • 4 is a flowchart for explaining in more detail the step of deriving the productivity loss prediction model of FIG. 1
  • FIG. 5 is a view showing an example of applying the tissue health index evaluation method according to an embodiment of the present invention
  • FIG. 5(a) is an example of calculating the productivity loss of the tissue
  • FIG. 5(b) is an example of calculating the absolute and relative influences on the productivity loss for each major disease factor.
  • the tissue health index evaluation method receives information on the prevalence of each major disease factor of a member regarding a plurality of major disease factors set in advance from a database including factor control research information.
  • a productivity loss prediction model that predicts the degree of productivity loss of the organization using the step (S100), the step (S200) of receiving the member's attendance information according to each major disease factor, and the prevalence information for each major disease factor and the member's time and attendance information It may include the step of deriving (S300).
  • the tissue health index evaluation method derives a productivity loss prediction model using a database including factor control research information and member's attendance information according to each major disease factor, thereby determining the health status of members. It is characterized in that the current productivity loss of the organization is identified. This will be described in more detail as follows.
  • Factors that directly affect the working environment of employees can be largely divided into working conditions and employee environment. And factors affecting working conditions may include factors such as industry type, required skills and occupational type, employment type, working hours, shift work, and job autonomy. In addition, factors affecting the environment of members may include health management of members, welfare for members, and physical environment. These working conditions and the member environment affect the member's working environment, and the final member's health status can be derived by reflecting the individual member's resilience and other external stimuli. And the derived member's health status is expressed as member's attendance information that directly affects the productivity of the organization, that is, the member's Absenteeism and Presenteeism.
  • the health status of the member when the health status of the member is quantified, when the health status of the member is Q 1 or more, which is a predetermined value, it may be determined that there is no productivity loss due to the health status.
  • the health status of the member when the health status of the member is greater than or equal to Q 2 , which is a predetermined value, and less than Q 1 , it may be determined that productivity loss due to the member's presentism occurs.
  • Presentism means that the member went to work, but his performance decreased due to his or her health condition. If the member's health status worsens and Q is less than 1 , it may be determined that productivity loss due to the member's appcentism occurs. Absentism means that members are absent from work or leave early due to health conditions. That is, when the health status of the member is less than Q 1 , it may be determined that the productivity loss of the organization occurs due to the member's health status (presentism or absoluteism).
  • the self-report bias problem may occur because the organization itself responds to the work characteristics, the health status of the members, and the status of the members' health promotion activities.
  • the conventional method evaluates the management method of the organization rather than the direct health state of the member, it is difficult to derive a direct relationship between the health status of the member and the loss of productivity of the organization.
  • the index is calculated by uniformly evaluating the weights for each field without varying the weight.
  • the conventional method calculates an index based on a questionnaire response, data that can objectively determine the health status of members, such as biomarkers, is lacking.
  • the tissue health index evaluation method is the prevalence information for each major disease factor of the member with respect to a plurality of major disease factors set in advance from a database including factor control research information. And, by receiving the time and attendance information of the member according to each of the major disease factors, and using the prevalence information for each major disease factor and the time and attendance information of the member, a productivity loss prediction model for predicting the productivity loss of the tissue is derived. can do.
  • the organizational health index evaluation method derives a productivity loss prediction model using both data that can objectively understand the health status of members and data that can understand the working environment of members, and the health status of members and organizational productivity It is possible to calculate a tissue health index that can organically determine the relationship of loss.
  • the major disease factors refer to major diseases that directly affect productivity loss
  • the risk factors to be described later refer to factors that do not directly affect productivity loss, but affect major disease factors.
  • the risk factors for the onset may include antecedent disease factors and health-influencing factors.
  • Antecedent disease factors are factors that increase the likelihood of developing a major disease agent in the future rather than causing a direct loss of productivity
  • a health-influencing factor is a factor that increases the likelihood of developing a leading disease agent and/or major disease factors.
  • tissue health index evaluation method according to an embodiment of the present invention will be described in more detail.
  • a factor-controlled study is a research method that investigates the relationship between a factor and a disease by tracing a group exposed to and without exposure to a specific factor and comparing the incidence rate of the disease being studied. It is also called a cohort study.
  • factor control study information may be used to derive a predictive model for productivity loss as well as the prevalence for each major disease factor.
  • the factor control study information can be utilized in predicting the degree of loss of tissue productivity due to the risk factors to be described later.
  • the database including the factor control study information according to an embodiment of the present invention, as shown in Figs. 3 (a) and 3 (b), the population composition (gender and gender) of subjects who have been screened for a preset period and age) and information on the prevalence, incidence, and recovery rate according to major disease factors by year.
  • the database may include information on subjects who have been screened from 2011 to 2016. Information on the prevalence, etc. of the disease to be investigated can be confirmed using biomarkers, etc. at the time of examination.
  • this is only an example, and may additionally include more various information about the subject (member) to be examined and the disease.
  • the population composition may be categorized based on a specific age and gender.
  • the population may be divided into four groups by distinguishing men and women based on the age of 40.
  • obesity and gastric diseases are the target diseases in FIG. 3( b )
  • more various diseases may be investigated as the target diseases.
  • cardiovascular diseases, depressive diseases, sleep diseases, etc. may be included as diseases to be investigated.
  • examination subjects in the database may be categorized for each organization. For example, by dividing the subject to be examined into members belonging to the organization A, organization B, and organization C, information on the disease to be investigated may be grasped for each organization.
  • the major disease factors refer to diseases that directly affect the loss of tissue productivity.
  • major disease factors may include cardiovascular disease, allergic disease, respiratory disease, digestive disease, depression/anxiety disease, and sleep disease.
  • cardiovascular diseases include stroke, transient cerebral ischemia, angina pectoris, myocardial infarction, atrial fibrillation, etc.
  • allergic diseases include rhinitis, atopic dermatitis, and allergic conjunctivitis
  • respiratory diseases include chronic obstructive pulmonary disease (COPD), asthma, tuberculosis, etc.
  • digestive diseases may include reflux esophagitis, acute gastritis, chronic gastritis, etc.
  • depressive diseases may include depressive disorders, anxiety disorders, etc.
  • sleep diseases may include sleep disorders.
  • the prevalence information for each major disease factor may be provided from a database including factor control study information as shown in FIG. 3 .
  • the prevalence information for each major disease of the members of the organization may be provided from the prevalence information for each major disease factor categorized for each tissue.
  • Time and attendance information of a member according to each major disease factor may be provided using questionnaire data about the member. More specifically, the questionnaire data may be data on the member's Absentism and Presentism due to a major disease factor.
  • the specific questionnaire content is not limited, and it is sufficient if members within the organization can respond by dividing Abcentism and Presentism by major disease factors.
  • the questionnaire may be a questionnaire about the number of early departures or absences due to cardiovascular disease among major disease factors, the time away from work during working hours, or the degree of inability to concentrate on work due to an allergic disease. there is.
  • presentism may mean a degree to which a member cannot concentrate while working due to a health condition, and questionnaire data regarding presentism may be dependent on the individual member's judgment. Therefore, it is possible to set up a response guide reflecting specific and detailed working conditions such as type of industry, required skills and job type, employment type, working hours, and shift work. In this way, subjective and biased responses of members can be prevented.
  • the effect on productivity loss by major disease factors means the degree to which major disease factors individually affect the productivity loss of the tissue, and is calculated from the member's questionnaire data.
  • the units of Absentism and Presentism caused by sleep disorders among major disease factors may be appropriately manipulated and expressed as percentages, and this may be expressed as the effect of productivity loss for each major disease factor.
  • the productivity loss prediction model is derived based on the prevalence information for each major disease factor and employee attendance information. That is, the productivity loss prediction model according to an embodiment of the present invention predicts the productivity loss by using both data on major disease factors using biomarkers and the attendance information of members to predict the productivity loss of the organization. model can be built.
  • the step of deriving a productivity loss prediction model is a step of calculating the productivity loss effect by major disease factor from the member's questionnaire data (S310), the prevalence information for each major disease factor and the major
  • the productivity loss effect for each major disease factor is calculated from the member's questionnaire data (S310).
  • the effect on productivity loss for each major disease factor can be calculated by Equation 1 below.
  • LPAi abentism time during the first preset period due to major disease factor i)/(total working hours during the first period)
  • LPPi is the first time period due to major disease factor i It's about presentationism. also am.
  • the first period is a value set in advance by reflecting the working conditions of the organization, such as the type of industry, required skills and occupational type, employment type, and whether to work in a shift.
  • the first period may be one month.
  • the total working hours during the first period may be 160 hours.
  • the industry or work type including irregular work may be determined based on the number of work hours rather than work hours within a specific period. For example, it is possible to set the number of shifts considering the average working hours per shift, and calculate the effect on productivity loss due to major disease factors by considering the Absentism or Presentism for the working hours corresponding to the number of shifts. there is.
  • productivity loss of the major disease factors can be calculated by multiplying the productivity loss effect of the major disease factors calculated from the questionnaire data of the members and the prevalence of the major disease factors set in advance from the database including the factor control study information.
  • the total productivity loss of the tissue is calculated by summing the productivity loss for each major disease factor ( S330 ).
  • the total productivity loss may be calculated by Equation 3 below.
  • pim is the prevalence of major disease factor i in tissue m.
  • the degree of loss of tissue productivity may be a value obtained by adding up degrees of loss of productivity according to a plurality of preset major disease factors.
  • FIG. 5( a ) An example of calculating the total productivity loss of an organization based on Equations 1 to 3 is shown in FIG. 5( a ).
  • cardiovascular disease, allergic disease, respiratory disease, digestive disease (esophagitis disease and stomach disease), depressive disease and sleep disease are set as six major disease factors.
  • the effect of productivity loss for each major disease factor expressed in Absentism and Presentism is calculated.
  • the productivity loss for each major disease factor is calculated by multiplying the calculated productivity loss effect for each major disease factor by the prevalence rate for each major disease factor.
  • the total productivity loss of the tissue due to the major disease factors is calculated by summing the productivity loss for each major disease factor (calculated to two decimal places in FIG. 5(a)).
  • step of deriving a productivity loss prediction model according to an embodiment of the present invention is to calculate the absolute influence and the relative influence of the major disease factors on the productivity loss from the productivity loss effects for each major disease factor. It may include further steps.
  • the absolute influence of the major disease factor on the productivity loss may be set as the absolute or presentism for each major disease factor.
  • the relative influence of the major disease factors on the productivity loss may be calculated as the product of the effect of the productivity loss for each major disease factor and the ratio of the number of members having the major disease factor to the total number of members of the tissue.
  • FIG. 5( b ) An example of calculating the absolute and relative influences of major disease factors on productivity loss is shown in FIG. 5( b ).
  • Fig. 5(b) in the case of absolute influence, it can be seen that depressive disease shows the greatest absolute influence in both Abcentism and Presentism.
  • Fig. 5(b) in the case of relative influence, it can be seen that sleep disorders show the largest relative influence in terms of Absentism, and digestive diseases show the largest relative influence in terms of Presentism.
  • the effect of the major disease factors on the productivity loss of the member and the effect on the productivity loss of the organization can be quantitatively grasped.
  • absolute and relative influences on productivity loss by major disease factors were calculated by dividing Abcentism and Presentism.
  • the absolute and relative influences on productivity loss by major disease factors are calculated based on the LPi of productivity loss effects by major disease factors calculated by Equation 1, which is the sum of Abcentism and Presentism. You may.
  • the step of deriving a productivity loss prediction model according to an embodiment of the present invention may further include calculating the total productivity loss, the total production time loss, and the total production wage loss.
  • Total lost productivity, total lost production time, and total lost wages are values that reflect the total number of members in the organization, respectively, the total loss of productivity in the organization, the total loss of working hours in the organization, and the total loss of wages in the organization due to the health status of the members, respectively.
  • the total productivity loss, the total production time loss, and the total production wage loss may be calculated by the following Equations 4 to 6, respectively.
  • the total production loss may be a value regarding the productivity loss reflecting the total number of members in the organization.
  • Tm is the average working hours of organization m.
  • the total production time loss may be a value related to the productivity loss reflecting the average working hours of the organization.
  • Wm is the average wage of organization m.
  • the total production wage loss may be a value related to the productivity loss reflecting the average wage of the organization.
  • FIG. 6 is a flowchart for schematically explaining a tissue health index evaluation method according to another embodiment of the present invention
  • FIG. 7 is a flowchart showing the productivity loss prediction model of FIG. 6, and
  • FIG. It is a diagram showing the path of influence.
  • 9 is a flowchart for explaining in more detail the step of deriving the productivity loss prediction model of FIG. 6, and
  • FIG. 10 is a view showing an example of an odds ratio used in the step of deriving the productivity loss prediction model of FIG. .
  • the tissue health index evaluation method comprises the steps of receiving, from a database including factor control research information, the prevalence information for each major disease factor of a member regarding a plurality of pre-set major disease factors (S100') , a step of receiving the member's risk factor information regarding a plurality of pre-set risk factors affecting the major disease factors from a database including factor control research information (S200'), the member's according to each major disease factor
  • the step of receiving time and attendance information (S300') and the step of deriving a productivity loss prediction model that predicts the productivity loss of the organization using the prevalence information for each major disease factor and the member's attendance information and onset risk factor information (S400') is included.
  • the tissue health index evaluation method uses a database including factor control research information and member's attendance information according to each major disease factor by deriving a productivity loss prediction model by using the member's health status. It is possible to predict the potential risk of loss of productivity in the organization
  • prevalence information for each major disease factor of a member regarding a plurality of preset major disease factors is provided from a database including factor control research information (S100'). This is the same as the step (S100) of receiving the prevalence information for each major disease factor of the member according to an embodiment of the present invention, and thus a description thereof will be omitted.
  • the member's risk factor information is provided with respect to a plurality of pre-set risk factors affecting major disease factors from a database including factor control research information (S200').
  • the onset risk factor is a factor that affects the current health status of a member and causes a loss of tissue productivity, and may include antecedent disease factors and health-influencing factors. Antecedent disease factors do not directly cause loss of productivity, but are factors that can increase the likelihood of developing major disease factors in the future.
  • Health influencing factors are factors for lifestyle and environment that influence major and predisposing disease factors.
  • the preceding disease factors may include diabetes, hypertension, obesity, and high cholesterol
  • the health-influencing factors may include smoking, drinking, lack of exercise, general stress, and job stress.
  • the member's attendance information according to each major disease factor is provided (S300'). Since this is the same as the step ( S300 ) of receiving time and attendance information of a member according to each major disease factor according to an embodiment of the present invention, a description thereof will be omitted.
  • a productivity loss prediction model for predicting the productivity loss of the organization is derived using the prevalence information for each major disease factor, attendance information of members, and disease risk factor information (S400').
  • the difference from the step (S300) of deriving a productivity loss predictive model according to an embodiment of the present invention is that a productivity loss predictive model is derived by further using the onset risk factor information.
  • FIG. 7 An example of a productivity loss prediction model according to another embodiment of the present invention is shown in FIG. 7 .
  • disease risk factors may affect major disease factors, and major disease factors may cause tissue productivity loss.
  • the risk factors for the onset may include antecedent disease factors and health influencing factors.
  • Antecedent disease factors may affect major disease factors, and health-influencing factors may directly affect major disease factors or may indirectly affect major disease factors by influencing antecedent disease factors. That is, the productivity loss prediction model according to the present invention can predict the productivity loss of the organization based on the member's current health status by deriving a relationship between the member's major disease factors and disease risk factors and the tissue's productivity loss.
  • the step of deriving a productivity loss predictive model may derive a productivity loss predictive model by reflecting the path in which the disease risk factor affects the productivity loss.
  • Fig. 8 shows an example in which all pathways in which the disease risk factors operate in the productivity loss prediction model are shown. 8 shows obesity as an onset risk factor (preceding disease factor).
  • obesity affects depressive disease, which is a major disease factor, and diabetes, which is another antecedent disease (the first and second pathways). And obesity interacts with cardiovascular disease, a major disease factor (3rd and 4th pathways). Diabetes affected by obesity affects cardiovascular disease (path 5), and cardiovascular disease and depressive disease influence each other (path 6 and 7). And finally, depressive and cardiovascular diseases affect productivity loss (paths 8 and 9).
  • productivity loss can also represent all pathways operating in the predictive model for health-affecting factors such as smoking and drinking. That is, the productivity loss prediction model according to the present invention reflects all pathways in which a member's disease risk factors affect other disease risk factors or major disease factors, ultimately affecting the tissue productivity loss, thereby improving the health of the members.
  • the relationship between state and organizational productivity loss can be derived organically.
  • the step of deriving a productivity loss prediction model is a step of calculating the sum of changes in the net incidence of major disease factors due to the onset risk factors (S410'), the major disease factors
  • the step of calculating the effect of the onset risk factor on the prevalence of the major disease factor from the sum of the changes in the star prevalence and the net incidence rate (S420'). From the effect of the onset risk factor on the prevalence of the major disease factor, the onset risk factor affects productivity loss.
  • the method may further include calculating the weight of the influence (S430') and calculating the risk index from the weight of the influence of the disease risk factor on the productivity loss (S440').
  • the sum of changes in the net incidence of major disease factors due to the onset risk factors is calculated (S410').
  • the sum of changes in net incidence of major disease factors due to risk factors may mean the sum of changes in all pathways in which onset risk factors affect productivity loss, as described above.
  • the sum of changes in the net incidence of major disease factors due to the onset risk factors may be calculated by Equation 7 below.
  • i is the major disease factor
  • j is the risk factor for the onset
  • nji is the net incidence of the major disease factor i by the risk factor j
  • p j is the prevalence of the risk factor j
  • OR i is the odds ratio to the incidence rate is the odds ratio of the incidence rate for the major disease factor i of the risk factor j
  • OR r is the odds ratio for the recovery rate is the odds ratio of the recovery rate for the major disease factor i of the onset risk factor j
  • pi is the prevalence of the major disease factor i.
  • the odds ratio is a value for determining the causal relationship between the independent variable and the dependent variable in a factor control study.
  • the independent variable can be set as an onset risk factor and the dependent variable can be set as a major disease factor.
  • An example of an odds ratio used in a method for evaluating a tissue health index according to another embodiment of the present invention is shown in FIG. 10 .
  • the sum of the changes in the net incidence of major disease factors due to the onset risk factors may mean the effect of the onset risk factors on the changes in the incidence rates of the major disease factors affecting productivity loss.
  • the risk factors for invention include antecedent disease factors and health-influencing factors. Therefore, by replacing the onset risk factor with the preceding disease factor or health-influencing factor in Equation 7, the sum of changes in the net incidence rate of the major disease factor due to the preceding disease factor or the net incidence rate of the major disease factor due to the health-influencing factor It is also possible to calculate the sum of the changes individually.
  • the antecedent disease factor may be expressed as k
  • the health influence factor may be expressed as l.
  • Equation 7 can be derived from Equation 8 below.
  • ni is the net incidence of major disease factor i
  • Ii is the incidence of major disease factor i
  • Ri is the recoverer of major disease factor i
  • P is the total population
  • Pi is the prevalence of major disease factor i
  • i i is the incidence of major disease factor i
  • ri is the recovery rate of major disease factor i
  • ' means the changed value.
  • the effect of the onset risk factor on the prevalence of the major disease factor is calculated from the sum of the changes in the prevalence and net incidence for each major disease factor (S420').
  • the effect of the onset risk factors on the prevalence of major disease factors may be calculated by Equation 9 below.
  • the effect of the onset risk factor on the prevalence of the major disease factor may be expressed as an event in which the major disease factor is newly onset due to the onset risk factor.
  • the weight of the effect of the onset risk factor on the productivity loss is calculated from the effect of the onset risk factor on the prevalence of the major disease factor (S430').
  • the weight of the effect of the disease risk factor on productivity loss may be calculated by Equation 10 below.
  • LPi denotes the effect on productivity loss due to the major disease factor i, derived from Equation 1 above.
  • the disease risk index is calculated from the weight of the effect of the disease risk factor on the productivity loss (S440').
  • the incidence risk index may be calculated by Equation 11 below.
  • the onset risk index is a value that considers the weight of the effect of the onset risk factor on the loss of productivity and the prevalence of the onset risk factor.
  • the potential risk that the onset risk factor can affect the major disease factors and ultimately cause a loss of tissue productivity. It is an indicator that quantifies and indicates factors. Based on this, it is possible to predict the potential risk of loss of productivity in the organization based on the current health status of the members.
  • the onset risk factors include both antecedent disease factors and health-influencing factors, and the antecedent disease risk index based on the antecedent disease factors and the health-affecting risk index based on the health-influencing factors may be calculated, respectively. there is.
  • the database including the factor control study information information on the prevalence of major disease factors, etc. may be categorized for each organization. Based on this, the degree of productivity loss between tissues and the risk index of disease can be visualized and expressed as a graph.
  • the calculated loss of productivity of the corresponding tissue is scored as a standard score and this can be expressed as an absolute loss of productivity.
  • the calculated productivity loss degree of the corresponding organization may be standardized and expressed as a relative productivity loss degree.
  • tissue health index evaluation method according to another embodiment of the present invention will be described with reference to FIG. 11 .
  • FIG. 11 is a graph comparing the degree of productivity loss and the incidence risk index between tissues, and FIG. 11 ( a ) shows the absolute productivity loss degree and the absolute incidence risk index, and FIG. 11 ( b ) shows the relative productivity loss degree and the relative incidence risk index. . 11 shows the productivity loss and disease risk index of the entire organization in the database including organization A, B, and C and factor control study information, respectively.
  • the absolute productivity loss, relative productivity loss, absolute disease risk index, and relative disease risk index shown in FIG. 11 are each standard-scored values, and in order to intuitively represent the current state of the tissue, the greater the value, the greater the productivity loss.
  • the degree or risk index was shown to be low (ie, the closer to the upper right corner in FIG. 11, the lower the productivity loss).
  • tissue A has a low absolute productivity loss, so productivity loss according to the member's current health status is high, but the absolute risk index is higher than the average, so future productivity loss will be lower. predicted
  • organization B is below average in both absolute productivity loss and absolute risk index.
  • tissue C both the absolute productivity loss and absolute risk index are higher than the average, so low productivity loss is predicted not only now but also in the future.
  • tissue A shows the lowest relative productivity loss compared to other companies, but has a higher relative risk index than tissue B, and is predicted to have lower productivity loss than tissue B in the future.
  • organization B shows the lowest relative risk index compared to other companies, so it is predicted that productivity loss will be higher than other companies in the future.
  • organization C has both a higher relative productivity loss and a higher relative risk index than other companies, so it is expected to maintain a lower productivity loss compared to other companies now and in the future. In this way, by calculating the absolute and relative values for the productivity loss degree and the disease risk index, respectively, the current productivity loss degree and the potential productivity loss risk of the organization can be compared with those of other companies based on the member's current health status. .
  • the calculated productivity loss and disease risk index may be categorized.
  • the members may be divided into four population groups according to gender based on the age of 40, and the disease risk index may be individually calculated for each population group.
  • a weighted average may be calculated in consideration of the number of members for each corresponding population group within an organization, and this may be set as an outbreak risk index. This allows us to understand the health status of each population group within an organization and predict the potential risk of loss of productivity. That is, it is possible to identify a group in an organization that is vulnerable to loss of health and productivity according to gender and age. This can be equally applied to the degree of productivity loss.
  • the tissue health index evaluation method and the computer program executing the same according to the embodiments of the present invention, the major disease factors of the member in relation to a plurality of major disease factors preset from a database including factor control study information Productivity loss for receiving prevalence information for each disease factor and time and attendance information of the member according to each of the major disease factors, and predicting the degree of productivity loss of the tissue using the prevalence information for each major disease factor and time and attendance information of the member It is also possible to derive a predictive model.
  • the organizational health index evaluation method and the computer program executing the same use both data that can objectively determine the health status of a member and data that can identify the member's working environment, so that productivity loss is also By deriving a predictive model, it is possible to calculate the organizational health index that can organically determine the relationship between the health status of members and the loss of productivity of the organization. predictable.
  • the embodiment according to the present invention described above may be implemented in the form of a computer program that can be executed through various components on a computer, and such a computer program may be recorded in a computer-readable medium.
  • the medium may be to store a program executable by a computer. Examples of the medium include a hard disk, a magnetic medium such as a floppy disk and a magnetic tape, an optical recording medium such as CD-ROM and DVD, a magneto-optical medium such as a floppy disk, and those configured to store program instructions, including ROM, RAM, flash memory, and the like.
  • the computer program may be specially designed and configured for the present invention, or may be known and available to those skilled in the art of computer software.
  • Examples of the computer program may include not only machine language codes such as those generated by a compiler, but also high-level language codes that can be executed by a computer using an interpreter or the like.
  • connection or connection members of the lines between the components shown in the drawings illustratively represent functional connections and/or physical or circuit connections, and in an actual device, various functional connections, physical connections that are replaceable or additional may be referred to as connections, or circuit connections.
  • connection or circuit connections unless there is a specific reference such as "essential” or "importantly", it may not be a necessary component for the application of the present invention.
  • the present invention can be applied to a method for evaluating a tissue health index and a computer program-related industry for executing the same.

Landscapes

  • Engineering & Computer Science (AREA)
  • Business, Economics & Management (AREA)
  • Human Resources & Organizations (AREA)
  • Strategic Management (AREA)
  • Entrepreneurship & Innovation (AREA)
  • Economics (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Health & Medical Sciences (AREA)
  • Data Mining & Analysis (AREA)
  • General Business, Economics & Management (AREA)
  • Quality & Reliability (AREA)
  • Tourism & Hospitality (AREA)
  • Physics & Mathematics (AREA)
  • Operations Research (AREA)
  • General Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Marketing (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Educational Administration (AREA)
  • Game Theory and Decision Science (AREA)
  • Development Economics (AREA)
  • Biomedical Technology (AREA)
  • Databases & Information Systems (AREA)
  • Pathology (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Abstract

One embodiment of the present invention provides a group health index evaluation method for evaluating a health index of a group on the basis of the health status of group members, the method comprising the steps of: for a plurality of preset major disease factors, receiving prevalence information of the group members for each of the preset major disease factors from a database containing factor-control study information; receiving tardiness-and-absence information of the group members for each of the major disease factors; and using the prevalence information for each of the major disease factors and the tardiness-and-absence information of the group members to derive a productivity loss prediction model for predicting productivity loss in the group.

Description

조직 건강 지수 평가 방법 및 이를 실행하는 컴퓨터 프로그램Organizational health index evaluation method and computer program executing the same
본 발명의 실시예들은 조직 건강 지수 평가 방법 및 이를 실행하는 컴퓨터 프로그램에 관한 것이다.Embodiments of the present invention relate to a method for evaluating a tissue health index and a computer program for executing the same.
최근 조직 내 구성원의 건강을 증진하여 조직의 생산성 향상을 도모하기 위한 관점에서, 기업을 비롯한 조직의 건강 경영의 중요성이 증대되고 있다. 건강 경영은 건강한 업무 수행의 동기를 부여할 수 있는 직장 환경을 조성하여, 조직의 실적 개선을 도모하는 경영 방법을 의미한다. In recent years, the importance of health management of organizations, including companies, is increasing from the viewpoint of promoting the health of members within the organization to improve the productivity of the organization. Health management refers to a management method that promotes organizational performance improvement by creating a work environment that can motivate healthy work performance.
이러한 건강 경영을 효과적으로 실시하기 위해서는 조직의 경영 환경과 구성원의 특성을 충분히 반영하고, 객관적이면서 세부적인 지표가 필요하다. 즉, 다양한 구성원들의 생활 및 근무 환경, 생리학적 요인 등에 따른 건강 수준을 객관적으로 파악하고, 이를 구성원 개인의 건강보다는 조직 경영의 입장에서 구성원 생산성의 특성을 반영할 필요가 있다. 그러나 종래의 조직 건강 지수는 구성원의 건강 상태를 객관적으로 나타낼 수 있는 바이오마커(Biomarker)보다는 문진 데이터만을 기초로 하고 있기 때문에, 자가 보고(self-reported)에 의한 편향된 해석이 우려된다.In order to effectively implement such health management, objective and detailed indicators are needed that sufficiently reflect the management environment of the organization and the characteristics of its members. In other words, it is necessary to objectively grasp the health level according to the living and working environment of various members, physiological factors, etc., and to reflect the characteristics of member productivity from the point of view of organizational management rather than individual health of each member. However, since the conventional tissue health index is based only on questionnaire data rather than a biomarker that can objectively represent a member's health status, biased interpretation by self-reported is concerned.
전술한 배경기술은 발명자가 본 발명의 도출을 위해 보유하고 있었거나, 본 발명의 도출 과정에서 습득한 기술 정보로서, 반드시 본 발명의 출원 전에 일반 공중에게 공개된 공지기술이라 할 수는 없다.The above-mentioned background art is technical information possessed by the inventor for derivation of the present invention or acquired in the process of derivation of the present invention, and cannot necessarily be said to be a known technique disclosed to the general public prior to the filing of the present invention.
본 발명의 실시예들은 요인 대조 연구 정보를 포함하는 데이터베이스와 구성원의 문진 데이터를 이용하여 생산성 손실도 예측모델을 도출함으로써, 조직의 생산성 손실도를 예측하는 조직 건강 지수 평가 방법 및 이를 실행하는 컴퓨터 프로그램을 제공하고자 한다.Embodiments of the present invention by deriving a productivity loss prediction model using a database including factor control research information and questionnaire data of members, a method for evaluating the organizational health index for predicting the productivity loss of the organization and a computer program executing the same would like to provide
본 발명의 일 실시예는 구성원의 건강 상태에 따른 조직의 건강 지수를 평가하는 조직 건강 지수 평가 방법으로서, 요인 대조 연구 정보를 포함하는 데이터베이스로부터 사전에 설정된 복수의 주요 질환 인자에 관한 상기 구성원의 상기 주요 질환 인자별 유병률 정보를 제공받는 단계, 상기 주요 질환 인자 각각에 따른 상기 구성원의 근태 정보를 제공받는 단계 및 상기 주요 질환 인자별 유병률 정보와 상기 구성원의 근태 정보를 이용하여 상기 조직의 생산성 손실도를 예측하는 생산성 손실도 예측모델을 도출하는 단계를 포함하는, 조직 건강 지수 평가 방법를 제공한다.An embodiment of the present invention is a tissue health index evaluation method for evaluating the health index of an organization according to the health status of a member, wherein the member's said member with respect to a plurality of major disease factors preset from a database including factor control study information Receiving the prevalence information for each major disease factor, receiving the time and attendance information of the member according to each of the major disease factors, and the loss of productivity of the tissue using the prevalence information for each major disease factor and the member's time and attendance information It provides a method for evaluating the tissue health index, including the step of deriving a productivity loss predictive model for predicting.
본 발명의 일 실시예에 있어서, 상기 주요 질환 인자 각각에 따른 상기 구성원의 근태 정보는 상기 구성원의 문진 데이터를 이용하여 제공받을 수 있다.In one embodiment of the present invention, the attendance information of the member according to each of the major disease factors may be provided by using the questionnaire data of the member.
본 발명의 일 실시예에 있어서, 상기 생산성 손실도 예측모델을 도출하는 단계는, 상기 구성원의 문진 데이터로부터 상기 주요 질환 인자별 생산성 손실 영향도를 산출하는 단계 및 상기 주요 질환 인자별 유병률 정보와 상기 주요 질환 인자별 생산성 손실 영향도를 이용하여 상기 생산성 손실도를 예측하는 생산성 손실도 예측모델을 도출하는 단계를 포함할 수 있다.In one embodiment of the present invention, the step of deriving the productivity loss predictive model comprises the steps of calculating the productivity loss effect for each major disease factor from the questionnaire data of the member, and the prevalence information for each major disease factor and the It may include deriving a productivity loss predictive model for predicting the productivity loss by using the productivity loss effect for each major disease factor.
본 발명의 일 실시예에 있어서, 상기 문진 데이터는 상기 주요 질환 인자로 인한 구성원의 앱센티즘(Absenteeism)과 프리젠티즘(Presenteeism)에 관한 데이터이며, 상기 앱센티즘은 상기 주요 질환 인자로 인한 구성원의 결근 또는 조퇴 시간이고, 상기 프리젠티즘은 상기 주요 질환 인자로 인한 구성원의 생산성 손실 정도일 수 있다In one embodiment of the present invention, the questionnaire data is data on Absenteeism and Presenteeism of a member due to the major disease factor, and the Absenteeism is the member due to the major disease factor. of absenteeism or early departure, and the presentism may be the degree of loss of productivity of members due to the major disease factor.
본 발명의 일 실시예에 있어서, 상기 주요 질환 인자별 생산성 손실 영향도 및 상기 생산성 손실도는 각각 이하의 식 (1) 및 식 (2)로 산출될 수 있다.In one embodiment of the present invention, the productivity loss effect by each major disease factor and the productivity loss degree may be calculated by the following Equations (1) and (2), respectively.
주요 질환 인자 i로 인한 생산성 손실 영향도
Figure PCTKR2021000637-appb-I000001
Effect of productivity loss due to major disease factor i
Figure PCTKR2021000637-appb-I000001
조직 m의 생산성 손실도
Figure PCTKR2021000637-appb-I000002
Loss of productivity of organization m
Figure PCTKR2021000637-appb-I000002
단, 여기서 LPAi는 (주요 질환 인자 i로 인한 사전에 설정된 제1 기간 동안의 앱센티즘 시간)/(상기 제1 기간 동안의 총 근무시간)이고, LPPi는 주요 질환 인자 i로 인한 상기 제1 기간 동안의 프리젠티즘 정도이며,
Figure PCTKR2021000637-appb-I000003
이고, pim는 조직 m의 주요 질환 인자 i의 유병률임.
provided that LPAi is (absentism time for a first preset period due to major disease factor i)/(total working hours during said first period), and LPPi is said first time period due to major disease factor i The degree of presentism during the period,
Figure PCTKR2021000637-appb-I000003
and pim is the prevalence of major disease factor i in tissue m.
본 발명의 일 실시예에 있어서, 상기 생산성 손실도 예측모델을 도출하는 단계는, 상기 주요 질환 인자별 생산성 손실 영향도를 상기 주요 질환 인자의 상기 생산성 손실도에 대한 절대 영향도로 설정하고, 상기 주요 질환 인자별 생산성 손실 영향도와 상기 조직의 전체 구성원 수 대비 상기 주요 질환 인자를 갖는 구성원 수의 비율의 곱을 상기 주요 질환 인자의 상기 생산성 손실도에 대한 상대 영향도로 설정하는 단계를 더 포함할 수 있다.In one embodiment of the present invention, the step of deriving the productivity loss prediction model comprises setting the degree of influence on productivity loss for each major disease factor as an absolute influence on the degree of productivity loss of the major disease factor, and The method may further include setting the product of the ratio of the effect of the productivity loss for each disease factor and the ratio of the number of members having the major disease factor to the total number of members of the tissue as the relative influence of the major disease factor on the productivity loss.
본 발명의 일 실시예에 있어서, 상기 생산성 손실도 예측모델을 도출하는 단계는, 생산성 손실이 발생하지 않은 경우를 기준으로 상기 생산성 손실도를 표준 점수화하여 상기 조직의 절대 생산성 손실도를 설정하고, 상기 요인 대조 연구 정보를 포함하는 데이터베이스 내의 전체 조직의 상기 생산성 손실도의 최댓값 및 최솟값을 기준으로 상기 생산성 손실도를 표준 점수화하여 상기 조직의 상대 생산성 손실도를 설정하는 단계를 더 포함할 수 있다.In one embodiment of the present invention, the step of deriving the productivity loss predictive model sets the absolute productivity loss degree of the organization by standardizing the productivity loss degree on the basis of a case in which no productivity loss occurs, The method may further include setting the relative productivity loss of the organization by standardizing the productivity loss on the basis of the maximum and minimum values of the productivity loss of the entire organization in the database including the factor control study information.
본 발명의 일 실시예에 있어서, 상기 생산성 손실도 예측모델을 도출하는 단계는, 총 생산성 손실, 총 생산 시간 손실 및 총 생산 임금 손실을 각각 이하의 식 (3) 내지 식 (5)로 산출하는 단계를 더 포함할 수 있다.In an embodiment of the present invention, the step of deriving the productivity loss prediction model comprises calculating the total productivity loss, the total production time loss, and the total production wage loss by the following Equations (3) to (5), respectively. It may include further steps.
조직 m의 총 생산 손실
Figure PCTKR2021000637-appb-I000004
total loss of production of tissue m
Figure PCTKR2021000637-appb-I000004
조직 m의 총 생산 시간 손실
Figure PCTKR2021000637-appb-I000005
total production time loss of tissue m
Figure PCTKR2021000637-appb-I000005
조직 m의 총 생산 임금 손실
Figure PCTKR2021000637-appb-I000006
Total production wage loss of organization m
Figure PCTKR2021000637-appb-I000006
단, 여기서 Pm는 조직 m의 구성원 수이고, Tm는 조직 m의 평균 근로 시간이고, Wm는 조직 m의 평균 임금임. where Pm is the number of members of organization m, Tm is the average working hours of organization m, and Wm is the average wage of organization m.
본 발명의 일 실시예에 있어서, 상기 주요 질환 인자는 심뇌혈관 질환, 알러지성 질환, 호흡기 질환, 소화기 질환, 우울 질환 및 수면 질환을 포함할 수 있다.In one embodiment of the present invention, the major disease factors may include cardiovascular disease, allergic disease, respiratory disease, digestive disease, depressive disease, and sleep disease.
본 발명의 일 실시예에 있어서, 상기 요인 대조 연구 정보를 포함하는 데이터베이스로부터 상기 주요 질환 인자에 영향을 미치는 사전에 설정된 복수의 발병 위험 인자에 관한 상기 구성원의 상기 발병 위험 인자 정보를 제공받는 단계를 더 포함하고, 상기 생산성 손실도 예측모델을 도출하는 단계는, 상기 발병 위험 인자 정보를 더 이용하여 상기 생산성 손실도 예측모델을 도출하는 단계일 수 있다.In one embodiment of the present invention, the step of receiving the onset risk factor information of the member regarding a plurality of preset risk factors affecting the major disease factors from a database including the factor control study information Further comprising, the step of deriving the productivity loss predictive model may be a step of deriving the productivity loss predictive model further using the disease risk factor information.
본 발명의 일 실시예에 있어서, 상기 생산성 손실도 예측모델을 도출하는 단계는, 상기 발병 위험 인자가 상기 생산성 손실에 영향을 미치는 모든 경로를 도출하고, 상기 경로의 개수에 따라 상기 발병 위험 인자가 상기 생산성 손실에 미치는 영향의 가중치를 산출하여 상기 생산성 손실도 예측모델을 도출할 수 있다.In one embodiment of the present invention, the step of deriving the productivity loss predictive model includes deriving all pathways in which the onset risk factor affects the productivity loss, and the onset risk factor is determined according to the number of the pathways. By calculating the weight of the influence on the productivity loss, it is possible to derive a predictive model of the productivity loss.
본 발명의 일 실시예에 있어서, 상기 생산성 손실도 예측모델을 도출하는 단계는, 상기 발병 위험 인자로 인한 상기 주요 질환 인자의 순발병률 변화의 총합을 산출하는 단계, 상기 주요 질환 인자별 유병률과 상기 순발병률 변화의 총합으로부터 상기 발병 위험 인자가 상기 주요 질환 인자의 유병률에 미치는 영향을 산출하는 단계, 상기 발병 위험 인자가 상기 주요 질환 인자의 유병률에 미치는 영향으로부터 상기 발병 위험 인자가 생산성 손실에 미치는 영향의 가중치를 산출하는 단계 및 상기 발병 위험 인자가 상기 생산성 손실에 미치는 영향의 가중치로부터 발병 위험 지수를 산출하는 단계를 포함할 수 있다.In an embodiment of the present invention, the step of deriving the productivity loss predictive model includes calculating the sum total of changes in the net incidence of the major disease factors due to the onset risk factors, the prevalence by each major disease factor and the Calculating the effect of the onset risk factor on the prevalence of the major disease factor from the sum of changes in net incidence, and the effect of the onset risk factor on productivity loss from the effect of the onset risk factor on the prevalence of the major disease factor It may include calculating the weight of the disease risk factor and calculating the disease risk index from the weight of the effect on the productivity loss.
본 발명의 일 실시예에 있어서, 상기 발병 위험 인자로 인한 상기 주요 질환 인자의 순발병률 변화의 총합, 상기 발병 위험 인자가 상기 주요 질환 인자의 유병률에 미치는 영향, 상기 발병 위험 인자가 상기 생산성 손실에 미치는 영향의 가중치 및 상기 발병 위험 지수는 이하의 식 (6) 내지 (9)로 산출될 수 있다.In one embodiment of the present invention, the sum of changes in the net incidence of the major disease factors due to the onset risk factors, the effect of the onset risk factors on the prevalence of the major disease factors, and the onset risk factors affect the productivity loss The weight of the influence and the disease risk index can be calculated by the following formulas (6) to (9).
발병 위험 인자 j로 인한 주요 질환 인자 i의 순발병률의 변화의 총합
Figure PCTKR2021000637-appb-I000007
Sum of changes in net incidence of major disease factor i due to risk factor j
Figure PCTKR2021000637-appb-I000007
Figure PCTKR2021000637-appb-I000008
Figure PCTKR2021000637-appb-I000008
발병 위험 인자 j가 주요 질환 인자 i의 유병률에 미치는 영향Effect of risk factor j on prevalence of major disease factor i
Figure PCTKR2021000637-appb-I000009
Figure PCTKR2021000637-appb-I000009
발병 위험 인자 j가 생산성 손실에 미치는 영향의 가중치 werTLPj Weight of the effect of risk factor j on productivity loss werTLPj
Figure PCTKR2021000637-appb-I000010
Figure PCTKR2021000637-appb-I000010
발병 위험 지수
Figure PCTKR2021000637-appb-I000011
risk index
Figure PCTKR2021000637-appb-I000011
단, 여기서 i는 주요 질환 인자이고, j는 발병 위험 인자이고, nji는 발병 위험 인자 j에 의한 주요 질환 인자 i의 순발병률이고, pj는 발병 위험 인자 j의 유병률이고,
Figure PCTKR2021000637-appb-I000012
는 주요 질환 인자 i를 갖지 않는 구성원 중 발병 위험 인자 j를 갖지 않는 구성원의 주요 질환 인자 i의 발병률이고,
Figure PCTKR2021000637-appb-I000013
는 발병 위험 인자 j의 주요 질환 인자 i에 대한 발병률의 오즈비(odds ratio)이고,
Figure PCTKR2021000637-appb-I000014
는 주요 질환 인자 i를 갖는 구성원 중 발병 위험 인자 j를 갖지 않는 구성원의 주요 질환 인자 i의 회복률이고,
Figure PCTKR2021000637-appb-I000015
는 발병 위험 인자 j의 주요 질환 인자 i에 대한 회복률의 오즈비이고, pi는 주요 질환 인자 i의 유병률임. 또한 상기 오즈비는 상기 요인 대조 연구 정보를 포함하는 데이터베이스로부터 산출됨.
with the proviso that i is a major disease factor, j is an onset risk factor, n ji is the net incidence of the major disease factor i by the onset risk factor j, p j is the prevalence of the onset risk factor j,
Figure PCTKR2021000637-appb-I000012
is the incidence of major disease factor i among members without major disease factor i, without risk factor j,
Figure PCTKR2021000637-appb-I000013
is the odds ratio of the incidence rate for the major disease factor i of the risk factor j,
Figure PCTKR2021000637-appb-I000014
is the recovery rate of major disease factor i of members without risk factor j among members with major disease factor i,
Figure PCTKR2021000637-appb-I000015
is the odds ratio of the recovery rate for the major disease factor i of the onset risk factor j, and pi is the prevalence of the major disease factor i. In addition, the odds ratio is calculated from a database including the factor control study information.
본 발명의 일 실시예에 있어서, 상기 생산성 손실도 예측모델을 도출하는 단계는, 생산성 손실이 발생하지 않은 경우를 기준으로 상기 발병 위험 지수를 표준 점수화하여 상기 조직의 절대 발병 위험 지수를 설정하고, 상기 요인 대조 연구 정보를 포함하는 데이터베이스 내의 전체 조직의 상기 발병 위험 지수의 최댓값과 최솟값을 기준으로 상기 발병 위험 지수를 표준 점수화하여 상기 조직의 상대 발병 위험 지수를 설정하는 단계를 더 포함할 수 있다.In one embodiment of the present invention, the step of deriving the productivity loss predictive model comprises setting the absolute risk index of the tissue by standardizing the onset risk index on the basis of a case in which no productivity loss occurs, The method may further include setting the relative incidence risk index of the tissue by standardizing the onset risk index based on the maximum and minimum values of the onset risk index of the entire organization in the database including the factor control study information.
본 발명의 일 실시예에 있어서, 상기 발병 위험 인자는 상기 주요 질환 인자에 영향을 미치는 선행 질환 인자와, 상기 주요 질환 인자 또는 상기 선행 질환 인자에 영향을 미치는 건강 영향 인자를 포함하고, 상기 발병 위험 지수는 상기 선행 질환 인자에 의한 선행 질환 위험 지수와, 상기 건강 영향 인자에 의한 건강 영향 위험 지수를 포함할 수 있다.In one embodiment of the present invention, the onset risk factor includes a prior disease factor affecting the main disease factor, and a health-influencing factor affecting the main disease factor or the antecedent disease factor, and the onset risk The index may include a prior disease risk index due to the preceding disease factor and a health impact risk index due to the health influence factor.
본 발명의 일 실시예에 있어서, 상기 주요 질환 인자는 심뇌혈관 질환, 알러지성 질환, 호흡기 질환, 소화기 질환, 우울 질환 및 수면 질환을 포함하고, 상기 선행 질환 인자는 당뇨, 고혈압, 비만, 고콜레스테롤을 포함하고, 상기 건강 영향 인자는 흡연, 운동 부족, 일반 스트레스, 직무 스트레스, 음주를 포함할 수 있다.In one embodiment of the present invention, the major disease factors include cardiovascular diseases, allergic diseases, respiratory diseases, digestive diseases, depressive diseases and sleep diseases, and the preceding disease factors are diabetes, hypertension, obesity, and high cholesterol. Including, the health-influencing factors may include smoking, lack of exercise, general stress, job stress, and drinking.
본 발명의 일 실시예는, 컴퓨터를 이용하여 전술한 방법 중 어느 하나의 방법을 실행시키기 위하여 매체에 저장된 컴퓨터 프로그램을 제공한다.An embodiment of the present invention provides a computer program stored in a medium to execute any one of the methods described above using a computer.
전술한 것 외의 다른 측면, 특징, 이점이 이하의 도면, 특허청구범위 및 발명의 상세한 설명으로부터 명확해질 것이다.Other aspects, features and advantages other than those described above will become apparent from the following drawings, claims, and detailed description of the invention.
본 발명의 실시예들에 따른 조직 건강 지수 평가 방법 및 이를 실행하는 컴퓨터 프로그램은, 요인 대조 연구 정보를 포함하는 데이터베이스로부터 사전에 설정된 복수의 주요 질환 인자에 관한 상기 구성원의 상기 주요 질환 인자별 유병률 정보와, 상기 주요 질환 인자 각각에 따른 상기 구성원의 근태 정보를 제공받아, 상기 주요 질환 인자별 유병률 정보와 상기 구성원의 근태 정보를 이용하여 상기 조직의 생산성 손실도를 예측하는 생산성 손실도 예측모델을 도출할 수 있다.The tissue health index evaluation method and the computer program executing the same according to embodiments of the present invention, the member's prevalence information for each major disease factor with respect to a plurality of major disease factors set in advance from a database including factor control study information And, by receiving the time and attendance information of the member according to each of the major disease factors, and using the prevalence information for each major disease factor and the time and attendance information of the member, a productivity loss prediction model for predicting the productivity loss of the tissue is derived. can do.
본 발명의 실시예들에 따른 조직 건강 지수 평가 방법 및 이를 실행하는 컴퓨터 프로그램은 구성원의 건강 상태를 객관적으로 파악할 수 있는 데이터와 구성원의 근무 환경을 파악할 수 있는 데이터를 모두 이용하여 생산성 손실도 예측모델을 도출함으로써, 구성원의 건강 상태와 조직의 생산성 손실의 관계를 유기적으로 파악할 수 있는 조직 건강 지수를 산출할 수 있으며, 이를 통해 조직의 현재 생산성 손실도를 파악하고, 잠재적인 생산성 손실 위험을 예측할 수 있다.The organizational health index evaluation method and the computer program executing the same according to embodiments of the present invention use both the data that can objectively determine the health status of the member and the data that can identify the member's working environment as a predictive model for productivity loss By deriving this, it is possible to calculate the organizational health index that can organically understand the relationship between the health status of members and the loss of productivity of the organization, and through this, it is possible to identify the current level of productivity loss of the organization and predict the risk of potential loss of productivity there is.
도 1은 본 발명의 일 실시예에 따른 조직 건강 지수 평가 방법을 개략적으로 설명하기 위한 순서도이다.1 is a flowchart schematically illustrating a method for evaluating a tissue health index according to an embodiment of the present invention.
도 2는 구성원의 건강 상태와 조직의 생산성 손실에 관한 그래프이다.2 is a graph relating to the health status of the member and the loss of productivity of the organization.
도 3은 도 1의 요인 대조 연구 정보의 일 예를 나타내는 도면으로서, 도 3(a)는 연도별 인구 구성 정보를 나타내고, 도 3(b)는 연도별 조사 대상 질환에 관한 정보를 나타낸다.3 is a diagram illustrating an example of the factor control study information of FIG. 1 , wherein FIG. 3 (a) shows information on population composition by year, and FIG. 3 (b) shows information about a disease to be investigated by year.
도 4는 도 1의 생산성 손실 예측모델을 도출하는 단계를 보다 상세하게 설명하기 위한 순서도이다.4 is a flowchart for explaining in more detail the step of deriving the productivity loss prediction model of FIG. 1 .
도 5는 본 발명의 일 실시예에 따른 조직 건강 지수 평가 방법을 적용한 일 예를 나타내는 도면으로서, 도 5(a)는 조직의 생산성 손실도를 산출하는 일 예이고, 도 5(b)는 주요 질환 인자별 생산성 손실에 대한 절대 영향도와 상대 영향도를 산출하는 일 예이다.Figure 5 is a view showing an example of applying the tissue health index evaluation method according to an embodiment of the present invention, Figure 5 (a) is an example of calculating the productivity loss of the organization, Figure 5 (b) is the main This is an example of calculating the absolute influence and the relative influence on productivity loss by disease factor.
도 6은 본 발명의 다른 실시예에 따른 조직 건강 지수 평가 방법을 개략적으로 설명하기 위한 순서도이다.6 is a flowchart schematically illustrating a method for evaluating a tissue health index according to another embodiment of the present invention.
도 7은 도 6의 생산성 손실 예측모델을 나타내는 순서도이다.7 is a flowchart illustrating the productivity loss prediction model of FIG. 6 .
도 8은 발병 위험 인자가 생산성 손실에 영향을 미치는 경로를 나타내는 도면이다.8 is a diagram illustrating a pathway in which disease risk factors affect productivity loss.
도 9는 도 6의 생산성 손실 예측모델을 도출하는 단계를 보다 상세하게 설명하기 위한 순서도이다.9 is a flowchart for explaining in more detail the step of deriving the productivity loss prediction model of FIG.
도 10은 도 6의 생산성 손실 예측모델을 도출하는 단계에서 사용되는 오즈비의 일 예를 나타내는 도면이다.10 is a diagram illustrating an example of an odds ratio used in the step of deriving the productivity loss prediction model of FIG. 6 .
도 11은 조직 간 생산성 손실도와 발병 위험 지수를 비교하는 그래프로서, 도 11(a)는 절대 생산성 손실도와 절대 발병 위험 지수를 나타내고, 도 11(b)는 상대 생산성 손실도와 상대 발병 위험 지수를 나타낸다.11 is a graph comparing the degree of productivity loss and the incidence risk index between tissues, and FIG. 11 ( a ) shows the absolute productivity loss degree and the absolute incidence risk index, and FIG. 11 ( b ) shows the relative productivity loss degree and the relative incidence risk index. .
본 발명의 일 실시예는 구성원의 건강 상태에 따른 조직의 건강 지수를 평가하는 조직 건강 지수 평가 방법으로서, 요인 대조 연구 정보를 포함하는 데이터베이스로부터 사전에 설정된 복수의 주요 질환 인자에 관한 상기 구성원의 상기 주요 질환 인자별 유병률 정보를 제공받는 단계, 상기 주요 질환 인자 각각에 따른 상기 구성원의 근태 정보를 제공받는 단계 및 상기 주요 질환 인자별 유병률 정보와 상기 구성원의 근태 정보를 이용하여 상기 조직의 생산성 손실도를 예측하는 생산성 손실도 예측모델을 도출하는 단계를 포함하는, 조직 건강 지수 평가 방법를 제공한다.An embodiment of the present invention is a tissue health index evaluation method for evaluating the health index of an organization according to the health status of a member, wherein the member's said member with respect to a plurality of major disease factors preset from a database including factor control study information Receiving the prevalence information for each major disease factor, receiving the time and attendance information of the member according to each of the major disease factors, and the loss of productivity of the tissue using the prevalence information for each major disease factor and the member's time and attendance information It provides a method for evaluating the tissue health index, including the step of deriving a productivity loss predictive model for predicting.
본 발명은 다양한 변환을 가할 수 있고 여러 가지 실시예를 가질 수 있는 바, 특정 실시예들을 도면에 예시하고 상세한 설명에 상세하게 설명하고자 한다. 본 발명의 효과 및 특징, 그리고 그것들을 달성하는 방법은 도면과 함께 상세하게 후술되어 있는 실시예들을 참조하면 명확해질 것이다. 그러나 본 발명은 이하에서 개시되는 실시예들에 한정되는 것이 아니라 다양한 형태로 구현될 수 있다. Since the present invention can apply various transformations and can have various embodiments, specific embodiments are illustrated in the drawings and described in detail in the detailed description. Effects and features of the present invention, and a method of achieving them, will become apparent with reference to the embodiments described below in detail in conjunction with the drawings. However, the present invention is not limited to the embodiments disclosed below and may be implemented in various forms.
이하, 첨부된 도면을 참조하여 본 발명의 실시예들을 상세히 설명하기로 하며, 도면을 참조하여 설명할 때 동일하거나 대응하는 구성 요소는 동일한 도면부호를 부여하고 이에 대한 중복되는 설명은 생략하기로 한다.Hereinafter, embodiments of the present invention will be described in detail with reference to the accompanying drawings, and when described with reference to the drawings, the same or corresponding components are given the same reference numerals, and the overlapping description thereof will be omitted. .
이하의 실시예에서, 제1, 제2 등의 용어는 한정적인 의미가 아니라 하나의 구성 요소를 다른 구성 요소와 구별하는 목적으로 사용되었다. In the following embodiments, terms such as first, second, etc. are used for the purpose of distinguishing one component from another, not in a limiting sense.
이하의 실시예에서, 단수의 표현은 문맥상 명백하게 다르게 뜻하지 않는 한, 복수의 표현을 포함한다.In the following examples, the singular expression includes the plural expression unless the context clearly dictates otherwise.
이하의 실시예에서, 포함하다 또는 가지다 등의 용어는 명세서상에 기재된 특징, 또는 구성요소가 존재함을 의미하는 것이고, 하나 이상의 다른 특징들 또는 구성요소가 부가될 가능성을 미리 배제하는 것은 아니다. In the following embodiments, terms such as include or have means that the features or components described in the specification are present, and the possibility of adding one or more other features or components is not excluded in advance.
이하의 실시예에서, 막, 영역, 구성 요소 등의 부분이 다른 부분 위에 또는 상에 있다고 할 때, 다른 부분의 바로 위에 있는 경우뿐만 아니라, 그 중간에 다른 막, 영역, 구성 요소 등이 개재되어 있는 경우도 포함한다. In the following embodiments, when it is said that a part such as a film, region, or component is on or on another part, not only the case where it is directly on the other part, but also another film, region, or component is interposed therebetween Including cases where there is
도면에서는 설명의 편의를 위하여 구성 요소들이 그 크기가 과장 또는 축소될 수 있다. 예컨대, 도면에서 나타난 각 구성의 크기 및 두께는 설명의 편의를 위해 임의로 나타내었으므로, 본 발명이 반드시 도시된 바에 한정되지 않는다.In the drawings, the size of the components may be exaggerated or reduced for convenience of description. For example, since the size and thickness of each component shown in the drawings are arbitrarily indicated for convenience of description, the present invention is not necessarily limited to the illustrated bar.
어떤 실시예가 달리 구현 가능한 경우에 특정한 공정 순서는 설명되는 순서와 다르게 수행될 수도 있다. 예를 들어, 연속하여 설명되는 두 공정이 실질적으로 동시에 수행될 수도 있고, 설명되는 순서와 반대의 순서로 진행될 수 있다. Where certain embodiments are otherwise feasible, a specific process sequence may be performed different from the described sequence. For example, two processes described in succession may be performed substantially simultaneously, or may be performed in an order opposite to the order described.
이하의 실시예에서, 막, 영역, 구성 요소 등이 연결되었다고 할 때, 막, 영역, 구성 요소들이 직접적으로 연결된 경우뿐만 아니라 막, 영역, 구성요소들 중간에 다른 막, 영역, 구성 요소들이 개재되어 간접적으로 연결된 경우도 포함한다. 예컨대, 본 명세서에서 막, 영역, 구성 요소 등이 전기적으로 연결되었다고 할 때, 막, 영역, 구성 요소 등이 직접 전기적으로 연결된 경우뿐만 아니라, 그 중간에 다른 막, 영역, 구성 요소 등이 개재되어 간접적으로 전기적 연결된 경우도 포함한다.In the following embodiments, when a film, region, or component is connected, other films, regions, and components are interposed between the films, regions, and components as well as when the films, regions, and components are directly connected. It also includes cases where it is indirectly connected. For example, in this specification, when it is said that a film, a region, a component, etc. are electrically connected, not only the case where the film, a region, a component, etc. are directly electrically connected, but also other films, regions, components, etc. Indirect electrical connection is also included.
이하, 도 1 내지 도 5를 참조하여, 본 발명의 일 실시예에 따른 조직 건강 지수 평가 방법을 설명한다.Hereinafter, a method for evaluating a tissue health index according to an embodiment of the present invention will be described with reference to FIGS. 1 to 5 .
도 1은 본 발명의 일 실시예에 따른 조직 건강 지수 평가 방법을 개략적으로 설명하기 위한 순서도이고, 도 2는 구성원의 건강 상태와 조직의 생산성 손실에 관한 그래프이고, 도 3은 도 1의 요인 대조 연구 정보의 일 예를 나타내는 도면으로서, 도 3(a)는 연도별 인구 구성 정보를 나타내고, 도 3(b)는 연도별 조사 대상 질환에 관한 정보를 나타낸다. 도 4는 도 1의 생산성 손실 예측모델을 도출하는 단계를 보다 상세하게 설명하기 위한 순서도이고, 도 5는 본 발명의 일 실시예에 따른 조직 건강 지수 평가 방법을 적용한 일 예를 나타내는 도면으로서, 도 5(a)는 조직의 생산성 손실도를 산출하는 일 예이고, 도 5(b)는 주요 질환 인자별 생산성 손실에 대한 절대 영향도와 상대 영향도를 산출하는 일 예이다.1 is a flowchart for schematically explaining a method for evaluating a tissue health index according to an embodiment of the present invention, FIG. 2 is a graph related to the health status of a member and a loss of organizational productivity, and FIG. 3 is a factor contrast of FIG. As a diagram illustrating an example of research information, FIG. 3(a) shows information on population composition by year, and FIG. 3(b) shows information on a disease to be investigated by year. 4 is a flowchart for explaining in more detail the step of deriving the productivity loss prediction model of FIG. 1, and FIG. 5 is a view showing an example of applying the tissue health index evaluation method according to an embodiment of the present invention, FIG. 5(a) is an example of calculating the productivity loss of the tissue, and FIG. 5(b) is an example of calculating the absolute and relative influences on the productivity loss for each major disease factor.
도 1에 따르면, 본 발명의 일 실시예에 따른 조직 건강 지수 평가 방법은, 요인 대조 연구 정보를 포함하는 데이터베이스로부터 사전에 설정된 복수의 주요 질환 인자에 관한 구성원의 주요 질환 인자별 유병률 정보를 제공받는 단계(S100), 주요 질환 인자 각각에 따른 구성원의 근태 정보를 제공받는 단계(S200) 및 주요 질환 인자별 유병률 정보와 구성원의 근태 정보를 이용하여 조직의 생산성 손실도를 예측하는 생산성 손실도 예측모델을 도출하는 단계(S300)를 포함할 수 있다. 본 발명의 일 실시예에 따른 조직 건강 지수 평가 방법은 요인 대조 연구 정보를 포함하는 데이터베이스와 주요 질환 인자 각각에 따른 구성원의 근태 정보를 이용하여 생산성 손실도 예측모델을 도출함으로써, 구성원의 건강 상태에 따른 조직의 현재 생산성 손실도를 파악하는 것을 특징으로 한다. 이에 대해 보다 구체적으로 설명하면 다음과 같다.According to FIG. 1 , the tissue health index evaluation method according to an embodiment of the present invention receives information on the prevalence of each major disease factor of a member regarding a plurality of major disease factors set in advance from a database including factor control research information. A productivity loss prediction model that predicts the degree of productivity loss of the organization using the step (S100), the step (S200) of receiving the member's attendance information according to each major disease factor, and the prevalence information for each major disease factor and the member's time and attendance information It may include the step of deriving (S300). The tissue health index evaluation method according to an embodiment of the present invention derives a productivity loss prediction model using a database including factor control research information and member's attendance information according to each major disease factor, thereby determining the health status of members. It is characterized in that the current productivity loss of the organization is identified. This will be described in more detail as follows.
조직의 생산성에 영향을 미치는 다양한 요인들 중 구성원의 건강 상태가 조직의 생산성에 미치는 영향은 매우 중요하다. 구성원은 조직을 직접 구성하면서 조직의 업무를 실시하는 개체인 점에서, 구성원의 건강 상태는 조직의 생산성에 대해 직접적이고 장기적인 영향을 미칠 수 있다. 또한 구성원의 건강 상태로 인한 국가의 생산성 손실이 GDP 대비 약 5%에 이르고 있어(U.S. Chamber of Commerce(2016), Health and the Economy), 구성원의 건강 상태는 기업뿐만 아니라 국가의 생산성 손실에도 심대한 영향을 미칠 수 있다.Among the various factors that affect organizational productivity, the effect of the health status of members on organizational productivity is very important. Since members are individuals who directly compose an organization and perform organizational tasks, the health status of members can have a direct and long-term effect on organizational productivity. In addition, the national productivity loss due to the health status of the members is about 5% of GDP (US Chamber of Commerce (2016), Health and the Economy), so the health status of the members has a profound effect on the productivity loss of the company as well as the country. can affect
구성원의 근무 환경에 직접적인 영향을 미치는 요인은 크게 근무 조건과 구성원 환경으로 구분될 수 있다. 그리고 근무 조건에 영향을 미치는 요인으로는 업종, 요구 기술 및 직업 형태, 고용 형태, 근무 시간, 교대 근무 여부, 직무 자율성과 같은 요인이 있을 수 있다. 또한 구성원 환경에 영향을 미치는 요인으로는 구성원의 건강 관리, 구성원에 대한 복지 및 물리적 환경 등이 있을 수 있다. 이들 근무 조건과 구성원 환경이 구성원의 근무 환경에 영향을 미치며, 구성원 개인의 회복 탄력성과 기타 외부 자극을 반영하여 최종적인 구성원의 건강 상태가 도출될 수 있다. 그리고 도출된 구성원의 건강 상태는 조직의 생산성에 직접적인 영향을 미치는 구성원의 근태 정보, 즉 구성원의 앱센티즘(Absenteeism)과 프리젠티즘(Presenteeism)으로 발현된다.Factors that directly affect the working environment of employees can be largely divided into working conditions and employee environment. And factors affecting working conditions may include factors such as industry type, required skills and occupational type, employment type, working hours, shift work, and job autonomy. In addition, factors affecting the environment of members may include health management of members, welfare for members, and physical environment. These working conditions and the member environment affect the member's working environment, and the final member's health status can be derived by reflecting the individual member's resilience and other external stimuli. And the derived member's health status is expressed as member's attendance information that directly affects the productivity of the organization, that is, the member's Absenteeism and Presenteeism.
도 2에 나타낸 바와 같이, 구성원의 건강 상태를 수치화했을 때, 구성원의 건강 상태가 미리 정한 값인 Q1 이상일 경우, 건강 상태로 인한 생산성 손실은 없는 것으로 판정할 수 있다. 반면, 구성원의 건강 상태가 미리 정한 값인 Q2 이상 Q1 미만일 경우, 구성원의 프리젠티즘으로 인한 생산성 손실이 발생하는 것으로 판정할 수 있다. 프리젠티즘은 구성원이 출근은 했으나 건강 상태로 인해 성과가 떨어지는 것을 의미한다. 만약 구성원의 건강 상태가 더 악화되어 Q1 미만일 경우, 구성원의 앱센티즘으로 인한 생산성 손실이 발생하는 것으로 판정할 수 있다. 앱센티즘은 구성원이 건강 상태로 인해 결근 또는 조퇴하는 것을 의미한다. 즉, 구성원의 건강 상태가 Q1 미만인 경우, 구성원의 건강 상태(프리젠티즘 또는 앱센티즘)로 인해 조직의 생산성 손실이 발생하는 것으로 판정할 수 있다.As shown in FIG. 2 , when the health status of the member is quantified, when the health status of the member is Q 1 or more, which is a predetermined value, it may be determined that there is no productivity loss due to the health status. On the other hand, when the health status of the member is greater than or equal to Q 2 , which is a predetermined value, and less than Q 1 , it may be determined that productivity loss due to the member's presentism occurs. Presentism means that the member went to work, but his performance decreased due to his or her health condition. If the member's health status worsens and Q is less than 1 , it may be determined that productivity loss due to the member's appcentism occurs. Absentism means that members are absent from work or leave early due to health conditions. That is, when the health status of the member is less than Q 1 , it may be determined that the productivity loss of the organization occurs due to the member's health status (presentism or absoluteism).
이러한 점을 고려하여 세계 각국 및 글로벌 기업에서는 구성원의 건강을 증진시키고 건강 악화를 예방하여 조직의 생산성 손실을 방지하기 위한 건강 경영을 실시하고 있다. Taking this into consideration, countries and global companies around the world are implementing health management to improve the health of employees and prevent deterioration of health, thereby preventing organizational productivity loss.
이러한 건강 경영이 효과적으로 이루어지기 위해서는 조직 내 구성원의 근무 환경의 특성과 구성원의 건강 상태를 충분히 반영하면서, 동시에 구성원의 건강 상태와 조직의 생산성 손실의 관계를 유기적으로 도출할 수 있는 객관적인 지표가 필요하다. 그러나 현재까지는 구성원의 건강 상태와 조직의 생산성의 관계에 관한 객관적인 지표가 없어, 기업을 비롯한 조직에서는 구성원의 건강 상태에 대한 체계적인 데이터 관리의 미흡으로 인해 건강 경영의 어려움을 겪고 있다.In order for such health management to be effective, it is necessary to have an objective index that can organically derive the relationship between the health status of members and the loss of productivity of the organization while sufficiently reflecting the characteristics of the working environment and the health status of members within the organization. . However, until now, there is no objective indicator on the relationship between the health status of members and the productivity of the organization, and organizations including companies are experiencing difficulties in health management due to the lack of systematic data management on the health status of members.
종래의 방법은 조직 스스로 근무 특성, 구성원의 건상 실태 및 구성원 건강 증진 활동 현황에 대해서 응답하기 때문에 자기 보고에 의한 편향문제가 발생할 수 있다. 또한, 종래의 방법은 구성원의 직접적인 건강 상태보다는 조직의 경영 방법 위주로 평가하기 때문에 구성원의 건강 상태와 조직의 생산성 손실간의 직접적인 관계를 도출하기 어렵다. In the conventional method, the self-report bias problem may occur because the organization itself responds to the work characteristics, the health status of the members, and the status of the members' health promotion activities. In addition, since the conventional method evaluates the management method of the organization rather than the direct health state of the member, it is difficult to derive a direct relationship between the health status of the member and the loss of productivity of the organization.
또한, 다른 종래의 방법으로서 조직의 건강 관리 구조 및 실행을 5개 분야로 구분하여 평가하는 방법의 경우, 분야별로 가중치를 달리하지 않고 일률적으로 평가하여 지수를 산출하고 있다. 또한, 종래의 방법은 설문 응답 위주로 지수를 산출하고 있어, 바이오마커 등 구성원의 건강 상태를 객관적으로 파악할 수 있는 데이터가 결여되어 있다.In addition, as another conventional method, in the case of a method of classifying and evaluating the health management structure and execution of an organization into five fields, the index is calculated by uniformly evaluating the weights for each field without varying the weight. In addition, since the conventional method calculates an index based on a questionnaire response, data that can objectively determine the health status of members, such as biomarkers, is lacking.
이러한 문제점을 해결하기 위하여, 본 발명의 일 실시예에 따른 조직 건강 지수 평가 방법은 요인 대조 연구 정보를 포함하는 데이터베이스로부터 사전에 설정된 복수의 주요 질환 인자에 관한 상기 구성원의 상기 주요 질환 인자별 유병률 정보와, 상기 주요 질환 인자 각각에 따른 상기 구성원의 근태 정보를 제공받아, 상기 주요 질환 인자별 유병률 정보와 상기 구성원의 근태 정보를 이용하여 상기 조직의 생산성 손실도를 예측하는 생산성 손실도 예측모델을 도출할 수 있다. 이를 통해 조직 건강 지수 평가 방법은 구성원의 건강 상태를 객관적으로 파악할 수 있는 데이터와 구성원의 근무 환경을 파악할 수 있는 데이터를 모두 이용하여 생산성 손실도 예측모델을 도출하여, 구성원의 건강 상태와 조직의 생산성 손실의 관계를 유기적으로 파악할 수 있는 조직 건강 지수를 산출할 수 있다.In order to solve this problem, the tissue health index evaluation method according to an embodiment of the present invention is the prevalence information for each major disease factor of the member with respect to a plurality of major disease factors set in advance from a database including factor control research information. And, by receiving the time and attendance information of the member according to each of the major disease factors, and using the prevalence information for each major disease factor and the time and attendance information of the member, a productivity loss prediction model for predicting the productivity loss of the tissue is derived. can do. Through this, the organizational health index evaluation method derives a productivity loss prediction model using both data that can objectively understand the health status of members and data that can understand the working environment of members, and the health status of members and organizational productivity It is possible to calculate a tissue health index that can organically determine the relationship of loss.
여기서, 주요 질환 인자는 생산성 손실에 직접적인 영향을 미치는 주요 질환을 의미하며, 후술하는 발병 위험 인자는 생산성 손실에 직접적인 영향을 미치지는 않으나, 주요 질환 인자에 영향을 미치는 인자를 의미한다. 또한, 후술하는 바와 같이 발병 위험 인자는 선행 질환 인자와 건강 영향 인자를 포함할 수 있다. 선행 질환 인자는 직접적인 생산성 손실을 유발하기 보다는 향후 주요 질환 인자의 발병 가능성을 높이는 인자이며, 건강 영향 인자는 선행 질환 인자 및/또는 주요 질환 인자의 발병 가능성을 높이는 인자이다.Here, the major disease factors refer to major diseases that directly affect productivity loss, and the risk factors to be described later refer to factors that do not directly affect productivity loss, but affect major disease factors. In addition, as will be described later, the risk factors for the onset may include antecedent disease factors and health-influencing factors. Antecedent disease factors are factors that increase the likelihood of developing a major disease agent in the future rather than causing a direct loss of productivity, and a health-influencing factor is a factor that increases the likelihood of developing a leading disease agent and/or major disease factors.
이하, 본 발명의 일 실시예에 따른 조직 건강 지수 평가 방법에 대해 보다 상세히 설명하도록 한다Hereinafter, the tissue health index evaluation method according to an embodiment of the present invention will be described in more detail.
먼저, 요인 대조 연구 정보를 포함하는 데이터베이스로부터 사전에 설정된 복수의 주요 질환 인자에 관한 구성원의 주요 질환 인자별 유병률 정보를 제공받는다(S100). First, prevalence information for each major disease factor of the member regarding a plurality of preset major disease factors is provided from a database including factor control research information (S100).
요인 대조 연구는 특정 요인에 노출된 집단과 노출되지 않은 집단을 추적하고 연구 대상 질병의 발생률을 비교하여 요인과 질병 발생 관계를 조사하는 연구 방법으로서, 코호트(Cohort) 연구라고도 불린다. 본 발명의 일 실시예에서는 주요 질환 인자별 유병률을 비롯하여 생산성 손실도 예측모델을 도출하기 위해 요인 대조 연구 정보를 이용할 수 있다. 또한, 후술하는 발병 위험 인자로 인한 조직의 생산성 손실도를 예측하는데 있어서도 요인 대조 연구 정보가 활용될 수 있다.A factor-controlled study is a research method that investigates the relationship between a factor and a disease by tracing a group exposed to and without exposure to a specific factor and comparing the incidence rate of the disease being studied. It is also called a cohort study. In an embodiment of the present invention, factor control study information may be used to derive a predictive model for productivity loss as well as the prevalence for each major disease factor. In addition, the factor control study information can be utilized in predicting the degree of loss of tissue productivity due to the risk factors to be described later.
본 발명의 일 실시예에 따른 요인 대조 연구 정보를 포함하는 데이터베이스는, 도 3(a) 및 도 3(b)에 나타낸 바와 같이 사전에 설정된 기간동안 검진을 실시한 대상자에 관한 연도별 인구 구성(성별 및 나이)과 연도별 주요 질환 인자에 따른 유병률, 발병률, 회복률 등에 관한 정보를 포함할 수 있다. 예를 들면, 상기 데이터베이스는 2011년부터 2016년까지 검진을 실시한 대상자에 관한 정보를 포함할 수 있다. 조사 대상 질환의 유병률 등에 관한 정보는 검진 시 바이오마커 등을 이용하여 확인할 수 있다. 다만 이는 예시에 불과하고, 검진 대상자(구성원)와 질환에 관한 보다 다양한 정보를 추가로 포함할 수 있다.The database including the factor control study information according to an embodiment of the present invention, as shown in Figs. 3 (a) and 3 (b), the population composition (gender and gender) of subjects who have been screened for a preset period and age) and information on the prevalence, incidence, and recovery rate according to major disease factors by year. For example, the database may include information on subjects who have been screened from 2011 to 2016. Information on the prevalence, etc. of the disease to be investigated can be confirmed using biomarkers, etc. at the time of examination. However, this is only an example, and may additionally include more various information about the subject (member) to be examined and the disease.
구체적으로, 도 3(a)에는 연도별로 성별에 따라 구분된 인구수와 평균 나이가 기재되어 있으나, 특정 연령 및 성별을 기준으로 인구 구성을 카테고리화할 수 있다. 예를 들어, 만 40세를 기준으로 남녀를 구별하여 인구 구성을 4개의 집단으로 구분할 수 있다. 그리고 이렇게 구분된 인구 집단 각각에 대해 조사 대상 질병의 유병률, 발병률 및 회복률 등에 관한 정보를 수집함으로써, 인구 구성에 따른 조사 대상 질병의 추이를 확인할 수 있다. 또한, 도 3(b)에는 비만과 위 질환만을 조사 대상 질병으로 하고 있으나, 보다 다양한 질병을 조사 대상 질병으로 할 수 있다. 예를 들어, 비만과 위질환 외에도 심뇌혈관 질환, 우울 질환, 수면 질환 등을 조사 대상 질병으로 포함할 수 있다. 또한, 데이터베이스 내의 검진 대상자를 조직별로 카테고리할 수 있다. 예를 들어, 검진 대상자를 A 조직, B 조직, C 조직에 속하는 구성원으로 구분하여 조직별로 조사 대상 질병에 관한 정보를 파악할 수 있다. Specifically, although the number and average age of the population divided according to gender for each year are described in FIG. 3A , the population composition may be categorized based on a specific age and gender. For example, the population may be divided into four groups by distinguishing men and women based on the age of 40. In addition, by collecting information on the prevalence, incidence, and recovery rate of the disease to be investigated for each of the divided population groups, it is possible to check the trend of the disease to be investigated according to the population composition. In addition, although only obesity and gastric diseases are the target diseases in FIG. 3( b ), more various diseases may be investigated as the target diseases. For example, in addition to obesity and stomach diseases, cardiovascular diseases, depressive diseases, sleep diseases, etc. may be included as diseases to be investigated. In addition, examination subjects in the database may be categorized for each organization. For example, by dividing the subject to be examined into members belonging to the organization A, organization B, and organization C, information on the disease to be investigated may be grasped for each organization.
주요 질환 인자는 조직의 생산성 손실에 직접적인 영향을 미치는 질환을 의미한다. 본 발명의 일 실시예에서 주요 질환 인자는 심뇌혈관 질환, 알러지성 질환, 호흡기 질환, 소화기 질환, 우울/불안 질환 및 수면 질환을 포함할 수 있다. 구체적으로 심뇌혈관 질환은 뇌졸증, 일과성 뇌허혈, 협심증, 심근경색, 심방세동 등을, 알러지성 질환은 비염, 아토피, 알러지성 결막염 등을, 호흡기 질환은 만성폐쇄성 폐질환(COPD), 천식, 폐결핵 등을, 소화기 질환은 역류성 식도염, 급성 위염, 만성 위염 등을, 우울 질환은 우울 장애, 불안 장애 등을, 수면 질환은 수면 장애 등을 포함할 수 있다.The major disease factors refer to diseases that directly affect the loss of tissue productivity. In an embodiment of the present invention, major disease factors may include cardiovascular disease, allergic disease, respiratory disease, digestive disease, depression/anxiety disease, and sleep disease. Specifically, cardiovascular diseases include stroke, transient cerebral ischemia, angina pectoris, myocardial infarction, atrial fibrillation, etc., allergic diseases include rhinitis, atopic dermatitis, and allergic conjunctivitis, and respiratory diseases include chronic obstructive pulmonary disease (COPD), asthma, tuberculosis, etc. , digestive diseases may include reflux esophagitis, acute gastritis, chronic gastritis, etc., depressive diseases may include depressive disorders, anxiety disorders, etc., and sleep diseases may include sleep disorders.
주요 질환 인자별 유병률 정보는 도 3에 나타낸 바와 같이 요인 대조 연구 정보를 포함하는 데이터베이스로부터 제공받을 수 있다. 또한, 전술한 바와 같이 조직별로 카테고리화된 주요 질환 인자별 유병률 정보로부터 조직 내 구성원의 주요 질환별 유병률 정보를 제공받을 수 있다.The prevalence information for each major disease factor may be provided from a database including factor control study information as shown in FIG. 3 . In addition, as described above, the prevalence information for each major disease of the members of the organization may be provided from the prevalence information for each major disease factor categorized for each tissue.
다음, 주요 질환 인자 각각에 따른 구성원의 근태 정보를 제공받는다(S200). 주요 질환 인자 각각에 따른 구성원의 근태 정보는 구성원에 대한 문진 데이터를 이용하여 제공받을 수 있다. 보다 구체적으로, 문진 데이터는 주요 질환 인자로 인한 구성원의 앱센티즘과 프리젠티즘에 관한 데이터일 수 있다. 구체적인 설문 내용은 한정하지 않으며, 조직 내 구성원이 앱센티즘과 프리젠티즘을 주요 질환 인자별로 구분하여 응답할 수 있으면 충분하다. 예를 들어, 설문은 주요 질환 인자 중 심뇌혈관 질환으로 인한 조퇴 또는 결석의 횟수와 그로 인해 근무 시간 동안 근무 장소에서 이탈한 시간이나, 알러지성 질환으로 인해 근무에 집중하지 못한 정도에 관한 설문일 수 있다.Next, the member's attendance information according to each major disease factor is provided (S200). Time and attendance information of a member according to each major disease factor may be provided using questionnaire data about the member. More specifically, the questionnaire data may be data on the member's Absentism and Presentism due to a major disease factor. The specific questionnaire content is not limited, and it is sufficient if members within the organization can respond by dividing Abcentism and Presentism by major disease factors. For example, the questionnaire may be a questionnaire about the number of early departures or absences due to cardiovascular disease among major disease factors, the time away from work during working hours, or the degree of inability to concentrate on work due to an allergic disease. there is.
전술한 바와 같이 프리젠티즘은 건강 상태로 인해 구성원이 근무 중 집중하지 못한 정도를 의미할 수 있으며, 프리젠티즘에 관한 문진 데이터는 구성원 개인의 판단에 의존적일 수 있다. 따라서, 업종, 요구 기술 및 직업 형태 고용 형태, 근무 시간 및 교대 근무 여부 등과 같이 구체적이고 세부적인 근무 조건을 반영한 응답 가이드를 설정할 수 있다. 이를 통해 구성원의 주관적이고 편향된 응답을 방지할 수 있다.As described above, presentism may mean a degree to which a member cannot concentrate while working due to a health condition, and questionnaire data regarding presentism may be dependent on the individual member's judgment. Therefore, it is possible to set up a response guide reflecting specific and detailed working conditions such as type of industry, required skills and job type, employment type, working hours, and shift work. In this way, subjective and biased responses of members can be prevented.
다음, 주요 질환 인자별 유병률 정보와 구성원의 근태 정보를 이용하여 조직의 생산성 손실도를 예측하는 생산성 손실도 예측모델을 도출한다(S300).Next, a productivity loss prediction model for predicting the productivity loss of the organization is derived using the prevalence information for each major disease factor and the attendance information of the members (S300).
주요 질환 인자별 생산성 손실 영향도는 주요 질환 인자가 개별적으로 조직의 생산성 손실에 영향을 미치는 정도를 의미하며, 구성원의 문진 데이터로부터 산출한다. 예를 들어, 주요 질환 인자 중 수면 질환으로 인해 발생한 앱센티즘과 프리젠티즘의 단위를 적절히 조작하여 퍼센트로 나타내고, 이를 주요 질환 인자별 생산성 손실 영향도로 나타낼 수 있다.The effect on productivity loss by major disease factors means the degree to which major disease factors individually affect the productivity loss of the tissue, and is calculated from the member's questionnaire data. For example, the units of Absentism and Presentism caused by sleep disorders among major disease factors may be appropriately manipulated and expressed as percentages, and this may be expressed as the effect of productivity loss for each major disease factor.
생산성 손실도 예측모델은 주요 질환 인자별 유병률 정보와 구성원의 근태 정보를 바탕으로 도출된다. 즉, 본 발명의 일 실시예에 따른 생산성 손실도 예측모델은 바이오마커 등을 활용한 주요 질환 인자에 관한 데이터와, 구성원의 근태 정보를 모두 이용하여 조직의 생산성 손실도를 예측하는 생산성 손실도 예측모델을 구축할 수 있다.The productivity loss prediction model is derived based on the prevalence information for each major disease factor and employee attendance information. That is, the productivity loss prediction model according to an embodiment of the present invention predicts the productivity loss by using both data on major disease factors using biomarkers and the attendance information of members to predict the productivity loss of the organization. model can be built.
도 4에 나타낸 바와 같이, 생산성 손실도 예측모델을 도출하는 단계(S300)는, 구성원의 문진 데이터로부터 주요 질환 인자별 생산성 손실 영향도를 산출하는 단계(S310), 주요 질환 인자별 유병률 정보와 주요 질환 인자별 생산성 손실 영향도를 이용하여 주요 질환 인자별 생산성 손실도를 산출하는 단계(S320), 주요 질환 인자별 생산성 손실도를 합산하여 총 생산성 손실도를 산출하는 단계(S330)를 더 포함할 수 있다.As shown in FIG. 4 , the step of deriving a productivity loss prediction model (S300) is a step of calculating the productivity loss effect by major disease factor from the member's questionnaire data (S310), the prevalence information for each major disease factor and the major The step of calculating the productivity loss for each major disease factor by using the productivity loss effect for each disease factor (S320), and calculating the total productivity loss by summing the productivity loss for each major disease factor (S330). can
먼저, 구성원의 문진 데이터로부터 주요 질환 인자별 생산성 손실 영향도를 산출한다(S310). 주요 질환 인자별 생산성 손실 영향도는 이하의 수학식 1로 산출될 수 있다.First, the productivity loss effect for each major disease factor is calculated from the member's questionnaire data (S310). The effect on productivity loss for each major disease factor can be calculated by Equation 1 below.
[수학식 1][Equation 1]
주요 질환 인자 i로 인한 생산성 손실 영향도 LPi=LPAi+LPPiEffect of productivity loss due to major disease factor i LPi=LPAi+LPPi
여기서, LPAi는 (주요 질환 인자 i로 인한 사전에 설정된 제1 기간 동안의 앱센티즘 시간)/(제1 기간 동안의 총 근무 시간)이고, LPPi는 주요 질환 인자 i로 인한 제1 기간 동안의 프리젠티즘 정도이다. 또한
Figure PCTKR2021000637-appb-I000016
이다.
where LPAi is (absentism time during the first preset period due to major disease factor i)/(total working hours during the first period), and LPPi is the first time period due to major disease factor i It's about presentationism. also
Figure PCTKR2021000637-appb-I000016
am.
즉, 주요 질환 인자로 인한 앱센티즘과 프리젠티즘을 합한 값을 주요 질환 인자로 인한 생산성 손실 영향도로 설정할 수 있다. 제1 기간은 업종, 요구 기술 및 직업 형태, 고용 형태 및 교대 근무 여부 등과 같은 조직의 근무 조건을 반영하여 사전에 설정된 값이다. 본 발명의 일 실시예에서 제1 기간은 한 달일 수 있다. 또한, 제1 기간 동안의 총 근무 시간은 160 시간일 수 있다.That is, the sum of Absentism and Presentism due to major disease factors may be set as the effect of productivity loss due to major disease factors. The first period is a value set in advance by reflecting the working conditions of the organization, such as the type of industry, required skills and occupational type, employment type, and whether to work in a shift. In an embodiment of the present invention, the first period may be one month. Also, the total working hours during the first period may be 160 hours.
다른 실시예로, 비정기적인 근무를 포함하는 업종 또는 근무 형태에 대해서는 특정 기간 내의 근무 시간보다는 근무 횟수를 기준으로 판단할 수 있다. 예를 들어, 회당 평균 근무 시간을 고려하여 근무 횟수를 설정하고, 해당 근무 횟수에 상응하는 근무 시간 동안의 앱센티즘 또는 프리젠티즘을 고려하여, 주요 질환 인자로 인한 생산성 손실 영향도를 산출할 수 있다.In another embodiment, the industry or work type including irregular work may be determined based on the number of work hours rather than work hours within a specific period. For example, it is possible to set the number of shifts considering the average working hours per shift, and calculate the effect on productivity loss due to major disease factors by considering the Absentism or Presentism for the working hours corresponding to the number of shifts. there is.
다음, 주요 질환 인자별 유병률 정보와 주요 질환 인자별 생산성 손실 영향도를 이용하여 주요 질환 인자별 생산성 손실도를 산출한다(S320). 주요 질환 인자별 생산성 손실 영향도는 이하의 수학식 2로 산출될 수 있다.Next, the productivity loss for each major disease factor is calculated using the prevalence information for each major disease factor and the productivity loss effect for each major disease factor (S320). The effect on productivity loss for each major disease factor can be calculated by Equation 2 below.
[수학식 2][Equation 2]
주요 질환 인자 i의 생산성 손실도 = LPi*piLoss of productivity for major disease factor i = LPi*pi
여기서, pi는 주요 질환 인자 i의 유병률이다.where pi is the prevalence of major disease factor i.
즉, 구성원의 문진 데이터로부터 산출된 주요 질환 인자의 생산성 손실 영향도와, 요인 대조 연구 정보를 포함하는 데이터베이스로부터 사전에 설정된 주요 질환 인자의 유병률을 곱하여 주요 질환 인자의 생산성 손실도를 산출할 수 있다.That is, the productivity loss of the major disease factors can be calculated by multiplying the productivity loss effect of the major disease factors calculated from the questionnaire data of the members and the prevalence of the major disease factors set in advance from the database including the factor control study information.
다음, 주요 질환 인자별 생산성 손실도를 합산하여 조직의 총 생산성 손실도를 산출한다(S330). 총 생산성 손실도는 이하의 수학식 3으로 산출될 수 있다.Next, the total productivity loss of the tissue is calculated by summing the productivity loss for each major disease factor ( S330 ). The total productivity loss may be calculated by Equation 3 below.
[수학식 3][Equation 3]
조직 m의 생산성 손실도
Figure PCTKR2021000637-appb-I000017
Loss of productivity of organization m
Figure PCTKR2021000637-appb-I000017
여기서, pim는 조직 m의 주요 질환 인자 i의 유병률이다.where pim is the prevalence of major disease factor i in tissue m.
즉, 조직의 생산성 손실도는 미리 설정된 복수의 주요 질환 인자에 따른 생산성 손실도를 합산한 값일 수 있다.That is, the degree of loss of tissue productivity may be a value obtained by adding up degrees of loss of productivity according to a plurality of preset major disease factors.
상기 수학식 1 내지 수학식 3을 바탕으로 조직의 총 생산성 손실도를 계산한 일 예를 도 5(a)에 나타낸다. 도 5(a)에 나타낸 바와 같이, 심뇌혈관 질환, 알러지 질환, 호흡기 질환, 소화기 질환(식도염 질환 및 위 질환), 우울 질환 및 수면 질환을 6개의 주요 질환 인자로 설정한다. 다음, 구성원의 문진 데이터를 바탕으로 앱센티즘 및 프리젠티즘으로 표현되는 주요 질환 인자별 생산성 손실 영향도를 산출한다. 그리고 산출된 주요 질환 인자별 생산성 손실 영향도에 주요 질환 인자별 유병률을 곱하여 주요 질환 인자별 생산성 손실도를 산출한다. 또한 주요 질환 인자별 생산성 손실도를 합산하여 주요 질환 인자로 인한 조직의 총 생산성 손실도를 산출한다(도 5(a)에서는 소수점 둘째 자리까지 계산).An example of calculating the total productivity loss of an organization based on Equations 1 to 3 is shown in FIG. 5( a ). As shown in Fig. 5(a), cardiovascular disease, allergic disease, respiratory disease, digestive disease (esophagitis disease and stomach disease), depressive disease and sleep disease are set as six major disease factors. Next, based on the member's questionnaire data, the effect of productivity loss for each major disease factor expressed in Absentism and Presentism is calculated. Then, the productivity loss for each major disease factor is calculated by multiplying the calculated productivity loss effect for each major disease factor by the prevalence rate for each major disease factor. In addition, the total productivity loss of the tissue due to the major disease factors is calculated by summing the productivity loss for each major disease factor (calculated to two decimal places in FIG. 5(a)).
이와 같이 최종적으로 산출된 조직의 총 생산성 손실도는 주요 질환 인자별 유병률 정보와 구성원의 근태 정보를 기초로 산출된 값이다. 즉, 산출된 조직의 총 생산성 손실도는 수치화된 데이터와 구성원이 속한 조직의 근무 환경을 모두 반영하여 산출된 값이다. 따라서, 본 발명의 일 실시예에 따른 조직 건강 지수 평가 방법에 따르면, 객관적이면서도 조직의 특성 및 근무 환경을 충실히 반영한 데이터에 기초하여 조직의 생산성 손실도를 정량적으로 평가할 수 있다.The total productivity loss of the tissue finally calculated as described above is a value calculated based on the prevalence information for each major disease factor and the attendance information of the members. That is, the calculated total productivity loss of the organization is a value calculated by reflecting both the numerical data and the working environment of the organization to which the members belong. Therefore, according to the organizational health index evaluation method according to an embodiment of the present invention, it is possible to quantitatively evaluate the productivity loss of the organization based on data that faithfully reflects the characteristics and working environment of the organization while being objective.
또한, 본 발명의 일 실시예에 따른 생산성 손실도 예측모델을 도출하는 단계(S300)는, 주요 질환 인자별 생산성 손실 영향도로부터 생산성 손실에 대한 주요 질환 인자의 절대 영향도와 상대 영향도를 산출하는 단계를 더 포함할 수 있다.In addition, the step of deriving a productivity loss prediction model according to an embodiment of the present invention (S300) is to calculate the absolute influence and the relative influence of the major disease factors on the productivity loss from the productivity loss effects for each major disease factor. It may include further steps.
구체적으로, 구성원의 문진 데이터로부터 제공 받은 주요 질환 인자별 생산성 손실 영향도에 있어서, 주요 질환 인자별 앱센티즘 또는 프리젠티즘을 생산성 손실에 대한 주요 질환 인자의 절대 영향도로 설정할 수 있다. 또한, 주요 질환 인자의 생산성 손실에 대한 상대 영향도는, 주요 질환 인자별 생산성 손실 영향도와 조직의 전체 구성원 수 대비 주요 질환 인자를 갖는 구성원 수의 비율의 곱으로 산출될 수 있다.Specifically, in the effect of productivity loss for each major disease factor provided from the member's questionnaire data, the absolute influence of the major disease factor on the productivity loss may be set as the absolute or presentism for each major disease factor. In addition, the relative influence of the major disease factors on the productivity loss may be calculated as the product of the effect of the productivity loss for each major disease factor and the ratio of the number of members having the major disease factor to the total number of members of the tissue.
산출된 주요 질환 인자별 생산성 손실에 대한 절대 영향도는 각각의 구성원의 문진 데이터로부터 산출된 주요 질환 인자별 생산성 손실 영향도의 평균값이다. 따라서 상기 절대 영향도는 구성원 1인을 기준으로 생산성 손실에 영향을 미치는 정도로 판정할 수 있다. 반면, 산출된 주요 질환 인자별 생산성 손실에 대한 상대 영향도는 해당 주요 질환 인자를 갖는 구성원의 수와, 조직 내 구성원 전체 수를 고려하여 산출되는 값이다. 따라서 상기 상대 영향도는 조직을 기준으로 생산성 손실에 영향을 미치는 정도로 판정할 수 있다.The calculated absolute influence on productivity loss for each major disease factor is the average value of the productivity loss effect for each major disease factor calculated from the questionnaire data of each member. Therefore, the absolute influence can be determined to the extent that one member affects the productivity loss. On the other hand, the calculated relative influence on productivity loss for each major disease factor is a value calculated by considering the number of members having the corresponding major disease factor and the total number of members in the organization. Therefore, the relative influence can be determined to the extent that it affects the productivity loss based on the organization.
주요 질환 인자의 생산성 손실에 대한 절대 영향도와 상대 영향도를 계산한 일 예를 도 5(b)에 나타낸다. 도 5(b)에 나타낸 바와 같이, 절대 영향도의 경우, 앱센티즘과 프리젠티즘 모두 우울 질환이 가장 큰 절대 영향도를 나타내는 것을 알 수 있다. 또한, 상대 영향도의 경우, 앱센티즘의 면에서는 수면 질환이 가장 큰 상대 영향도를 나타내며, 프리젠티즘의 면에서는 소화기 질환이 가장 큰 상대 영향도를 나타내는 것을 알 수 있다. 이와 같이, 주요 질환 인자의 생산성 손실에 대한 절대 영향도와 상대 영향도를 산출함으로써, 주요 질환 인자가 구성원의 생산성 손실에 미치는 영향과 조직의 생산성 손실에 미치는 영향을 정량적으로 파악할 수 있다.An example of calculating the absolute and relative influences of major disease factors on productivity loss is shown in FIG. 5( b ). As shown in Fig. 5(b), in the case of absolute influence, it can be seen that depressive disease shows the greatest absolute influence in both Abcentism and Presentism. In addition, in the case of relative influence, it can be seen that sleep disorders show the largest relative influence in terms of Absentism, and digestive diseases show the largest relative influence in terms of Presentism. In this way, by calculating the absolute and relative influences of the major disease factors on the productivity loss, the effect of the major disease factors on the productivity loss of the member and the effect on the productivity loss of the organization can be quantitatively grasped.
한편, 도 5(b)에서는 앱센티즘과 프리젠티즘을 구분하여 주요 질환 인자별 생산성 손실에 대한 절대 영향도와 상대 영향도를 산출하였으나, 앱센티즘과 프리젠티즘을 합산하여 하나의 지표로 산출할 수도 있다. 예를 들어, 앱센티즘과 프리젠티즘이 합산된 값인, 상기 수학식 1로 산출된 주요 질환 인자별 생산성 손실 영향도 LPi를 기준으로 주요 질환 인자별 생산성 손실에 대한 절대 영향도와 상대 영향도를 산출할 수도 있다.On the other hand, in FIG. 5(b), absolute and relative influences on productivity loss by major disease factors were calculated by dividing Abcentism and Presentism. may be For example, the absolute and relative influences on productivity loss by major disease factors are calculated based on the LPi of productivity loss effects by major disease factors calculated by Equation 1, which is the sum of Abcentism and Presentism. You may.
또한, 본 발명의 일 실시예에 따른 생산성 손실도 예측모델을 도출하는 단계(S300)는 총 생산성 손실, 총 생산 시간 손실 및 총 생산 임금 손실을 산출하는 단계를 더 포함할 수 있다. 총 생산성 손실, 총 생산 시간 손실 및 총 생산 임금 손실은 조직의 구성원 전체 수를 반영한 값으로서, 각각 구성원의 건강 상태로 인해 발생한 조직의 전체 생산성 손실, 조직의 전체 근무 시간 손실 및 조직의 전체 임금 손실을 의미한다. 총 생산성 손실, 총 생산 시간 손실 및 총 생산 임금 손실은 각각 이하의 수학식 4 내지 수학식 6으로 산출될 수 있다.In addition, the step of deriving a productivity loss prediction model according to an embodiment of the present invention (S300) may further include calculating the total productivity loss, the total production time loss, and the total production wage loss. Total lost productivity, total lost production time, and total lost wages are values that reflect the total number of members in the organization, respectively, the total loss of productivity in the organization, the total loss of working hours in the organization, and the total loss of wages in the organization due to the health status of the members, respectively. means The total productivity loss, the total production time loss, and the total production wage loss may be calculated by the following Equations 4 to 6, respectively.
[수학식 4][Equation 4]
조직 m의 총 생산 손실
Figure PCTKR2021000637-appb-I000018
total loss of production of tissue m
Figure PCTKR2021000637-appb-I000018
여기서 Pm는 조직 m의 구성원 전체 수이다.where Pm is the total number of members of the organization m.
즉, 총 생산 손실은 조직 내의 구성원 전체 수를 반영한 생산성 손실에 관한 값일 수 있다.That is, the total production loss may be a value regarding the productivity loss reflecting the total number of members in the organization.
[수학식 5][Equation 5]
조직 m의 총 생산 시간 손실
Figure PCTKR2021000637-appb-I000019
total production time loss of tissue m
Figure PCTKR2021000637-appb-I000019
여기서 Tm는 조직 m의 평균 근로 시간이다.where Tm is the average working hours of organization m.
즉, 총 생산 시간 손실은 조직의 평균 근로 시간을 반영한 생산성 손실에 관한 값일 수 있다.That is, the total production time loss may be a value related to the productivity loss reflecting the average working hours of the organization.
[수학식 6][Equation 6]
조직 m의 총 생산 임금 손실
Figure PCTKR2021000637-appb-I000020
Total production wage loss of organization m
Figure PCTKR2021000637-appb-I000020
여기서 Wm는 조직 m의 평균 임금이다.where Wm is the average wage of organization m.
즉, 총 생산 임금 손실은 조직의 평균 임금을 반영한 생산성 손실에 관한 값일 수 있다.That is, the total production wage loss may be a value related to the productivity loss reflecting the average wage of the organization.
이와 같이 산출된 생산성 손실도를 바탕으로 조직의 현재 상태를 나타내는 다양한 값을 산출할 수 있으며, 조직 경영을 위한 지표로 이용할 수 있다.Based on the productivity loss calculated in this way, various values representing the current state of the organization can be calculated, and can be used as an index for organizational management.
이하, 도 6 내지 도 10을 참조하여 본 발명의 다른 실시예에 따른 조직의 건강 지수 평가 방법을 설명한다.Hereinafter, a method for evaluating an organization's health index according to another embodiment of the present invention will be described with reference to FIGS. 6 to 10 .
도 6은 본 발명의 다른 실시예에 따른 조직 건강 지수 평가 방법을 개략적으로 설명하기 위한 순서도이고, 도 7은 도 6의 생산성 손실 예측모델을 나타내는 순서도이고, 도 8은 발병 위험 인자가 생산성 손실에 영향을 미치는 경로를 나타내는 도면이다. 도 9는 도 6의 생산성 손실 예측모델을 도출하는 단계를 보다 상세하게 설명하기 위한 순서도이고, 도 10은 도 6의 생산성 손실 예측모델을 도출하는 단계에서 사용되는 오즈비의 일 예를 나타내는 도면이다.6 is a flowchart for schematically explaining a tissue health index evaluation method according to another embodiment of the present invention, FIG. 7 is a flowchart showing the productivity loss prediction model of FIG. 6, and FIG. It is a diagram showing the path of influence. 9 is a flowchart for explaining in more detail the step of deriving the productivity loss prediction model of FIG. 6, and FIG. 10 is a view showing an example of an odds ratio used in the step of deriving the productivity loss prediction model of FIG. .
본 발명의 다른 실시예에 따른 조직 건강 지수 평가 방법은, 요인 대조 연구 정보를 포함하는 데이터베이스로부터 사전에 설정된 복수의 주요 질환 인자에 관한 구성원의 주요 질환 인자별 유병률 정보를 제공받는 단계(S100'), 요인 대조 연구 정보를 포함하는 데이터베이스로부터 주요 질환 인자에 영향을 미치는 사전에 설정된 복수의 발병 위험 인자에 관한 구성원의 발병 위험 인자 정보를 제공받는 단계(S200'), 주요 질환 인자 각각에 따른 구성원의 근태 정보를 제공받는 단계(S300') 및 주요 질환 인자별 유병률 정보와 구성원의 근태 정보 및 발병 위험 인자 정보를 이용하여 조직의 생산성 손실도를 예측하는 생산성 손실도 예측모델을 도출하는 단계(S400')를 포함한다. 본 발명의 다른 실시예에 따른 조직 건강 지수 평가 방법은 요인 대조 연구 정보를 포함하는 데이터베이스와 주요 질환 인자 각각에 따른 구성원의 근태 정보를 이용하여 생산성 손실도 예측모델을 도출함으로써, 구성원의 건강 상태에 따른 조직의 잠재적인 생산성 손실 위험을 예측할 수 있다The tissue health index evaluation method according to another embodiment of the present invention comprises the steps of receiving, from a database including factor control research information, the prevalence information for each major disease factor of a member regarding a plurality of pre-set major disease factors (S100') , a step of receiving the member's risk factor information regarding a plurality of pre-set risk factors affecting the major disease factors from a database including factor control research information (S200'), the member's according to each major disease factor The step of receiving time and attendance information (S300') and the step of deriving a productivity loss prediction model that predicts the productivity loss of the organization using the prevalence information for each major disease factor and the member's attendance information and onset risk factor information (S400') ) is included. The tissue health index evaluation method according to another embodiment of the present invention uses a database including factor control research information and member's attendance information according to each major disease factor by deriving a productivity loss prediction model by using the member's health status. It is possible to predict the potential risk of loss of productivity in the organization
먼저, 요인 대조 연구 정보를 포함하는 데이터베이스로부터 사전에 설정된 복수의 주요 질환 인자에 관한 구성원의 주요 질환 인자별 유병률 정보를 제공받는다(S100'). 이는 본 발명의 일 실시예에 따른 구성원의 주요 질환 인자별 유병률 정보를 제공받는 단계(S100)와 동일하므로, 이에 대한 설명은 생략한다.First, prevalence information for each major disease factor of a member regarding a plurality of preset major disease factors is provided from a database including factor control research information (S100'). This is the same as the step (S100) of receiving the prevalence information for each major disease factor of the member according to an embodiment of the present invention, and thus a description thereof will be omitted.
다음, 요인 대조 연구 정보를 포함하는 데이터베이스로부터 주요 질환 인자에 영향을 미치는 사전에 설정된 복수의 발병 위험 인자에 관한 구성원의 발병 위험 인자 정보를 제공받는다(S200').Next, the member's risk factor information is provided with respect to a plurality of pre-set risk factors affecting major disease factors from a database including factor control research information (S200').
발병 위험 인자는 구성원의 현재 건강 상태에 영향을 미쳐 조직의 생산성 손실을 유발하는 인자로서, 선행 질환 인자와 건강 영향 인자를 포함할 수 있다. 선행 질환 인자는 직접적인 생산성 손실을 유발하지는 않으나, 향후 주요 질환 인자의 발병 가능성을 높일 수 있는 인자이다. 건강 영향 인자는 주요 질환 인자 및 선행 질환 인자에 영향을 주는 생활 습관 및 환경에 대한 인자이다. 본 발명의 다른 실시예에서 선행 질환 인자는 당뇨, 고혈압, 비만, 고콜레스테롤을 포함할 수 있으며, 건강 영향 인자는 흡연, 음주, 운동 부족, 일반 스트레스, 직무 스트레스를 포함할 수 있다.The onset risk factor is a factor that affects the current health status of a member and causes a loss of tissue productivity, and may include antecedent disease factors and health-influencing factors. Antecedent disease factors do not directly cause loss of productivity, but are factors that can increase the likelihood of developing major disease factors in the future. Health influencing factors are factors for lifestyle and environment that influence major and predisposing disease factors. In another embodiment of the present invention, the preceding disease factors may include diabetes, hypertension, obesity, and high cholesterol, and the health-influencing factors may include smoking, drinking, lack of exercise, general stress, and job stress.
다음, 주요 질환 인자 각각에 따른 구성원의 근태 정보를 제공받는다(S300'). 이는 본 발명의 일 실시예에 따른 주요 질환 인자 각각에 따른 구성원의 근태 정보를 제공받는 단계(S300)와 동일하므로, 이에 대한 설명은 생략한다.Next, the member's attendance information according to each major disease factor is provided (S300'). Since this is the same as the step ( S300 ) of receiving time and attendance information of a member according to each major disease factor according to an embodiment of the present invention, a description thereof will be omitted.
다음, 주요 질환 인자별 유병률 정보와 구성원의 근태 정보 및 발병 위험 인자 정보를 이용하여 조직의 생산성 손실도를 예측하는 생산성 손실도 예측모델을 도출한다(S400'). 본 발명의 일 실시예에 따른 생산성 손실도 예측모델을 도출하는 단계(S300)와 상이한 점은, 발병 위험 인자 정보를 더 이용하여 생산성 손실도 예측모델을 도출하는 점이다. 주요 질환 인자에 영향을 미치는 발병 위험 인자를 생산성 손실도 예측모델을 구축하는데 포함시킴으로써, 구성원의 현재 건강 상태가 조직의 잠재적인 생산성 손실 위험에 미치는 영향을 예측할 수 있다.Next, a productivity loss prediction model for predicting the productivity loss of the organization is derived using the prevalence information for each major disease factor, attendance information of members, and disease risk factor information (S400'). The difference from the step (S300) of deriving a productivity loss predictive model according to an embodiment of the present invention is that a productivity loss predictive model is derived by further using the onset risk factor information. By including the risk factors affecting the major disease factors in constructing the productivity loss prediction model, the effect of the member's current health status on the potential productivity loss risk of the organization can be predicted.
본 발명의 다른 실시예에 따른 생산성 손실도 예측모델의 일 예를 도 7에 나타낸다. 도 7에 나타낸 바와 같이, 발병 위험 인자는 주요 질환 인자에 영향을 미칠 수 있으며, 주요 질환 인자는 조직의 생산성 손실을 야기할 수 있다. 또한, 발병 위험 인자는 선행 질환 인자와 건강 영향 인자를 포함할 수 있다. 선행 질환 인자는 주요 질환 인자에 영향을 미칠 수 있고, 건강 영향 인자는 주요 질환 인자에 직접적으로 영향을 미칠 수 있나 선행 질환 인자에 영향을 미쳐 주요 질환 인자에 간접적으로 영향을 미칠 수 있다. 즉, 본 발명에 따른 생산성 손실도 예측모델은 구성원의 주요 질환 인자 및 발병 위험 인자와 조직의 생산성 손실 간의 관계를 도출하여, 구성원의 현재 건강 상태를 바탕으로 조직의 생산성 손실을 예측할 수 있다.An example of a productivity loss prediction model according to another embodiment of the present invention is shown in FIG. 7 . As shown in FIG. 7 , disease risk factors may affect major disease factors, and major disease factors may cause tissue productivity loss. In addition, the risk factors for the onset may include antecedent disease factors and health influencing factors. Antecedent disease factors may affect major disease factors, and health-influencing factors may directly affect major disease factors or may indirectly affect major disease factors by influencing antecedent disease factors. That is, the productivity loss prediction model according to the present invention can predict the productivity loss of the organization based on the member's current health status by deriving a relationship between the member's major disease factors and disease risk factors and the tissue's productivity loss.
또한, 본 발명의 일 실시예에 따른 생산성 손실도 예측모델을 도출하는 단계는 발병 위험 인자가 생산성 손실에 영향을 미치는 경로를 반영하여 생산성 손실도 예측모델을 도출할 수 있다.In addition, the step of deriving a productivity loss predictive model according to an embodiment of the present invention may derive a productivity loss predictive model by reflecting the path in which the disease risk factor affects the productivity loss.
도 8에 발병 위험 인자가 생산성 손실도 예측 모델에서 작동하는 모든 경로를 표시한 일 예를 나타낸다. 도 8에는 발병 위험 인자(선행 질환 인자)로서 비만을 나타냈다.Fig. 8 shows an example in which all pathways in which the disease risk factors operate in the productivity loss prediction model are shown. 8 shows obesity as an onset risk factor (preceding disease factor).
먼저, 비만은 주요 질환 인자인 우울 질환과 다른 선행 질환인 당뇨에 영향을 미친다(제1 경로 및 제2 경로). 그리고 비만은 주요 질환 인자인 심혈관 질환과 서로 영향을 미친다(제3 경로 및 제4 경로). 비만으로부터 영향을 받은 당뇨는 심혈관 질환에 영향을 미치며(제5 경로), 심혈관 질환과 우울 질환은 서로 영향을 미친다(제6 경로 및 제7 경로). 그리고 최종적으로 우울 질환과 심혈관 질환은 생산성 손실에 영향을 미친다(제8 경로 및 제9 경로).First, obesity affects depressive disease, which is a major disease factor, and diabetes, which is another antecedent disease (the first and second pathways). And obesity interacts with cardiovascular disease, a major disease factor (3rd and 4th pathways). Diabetes affected by obesity affects cardiovascular disease (path 5), and cardiovascular disease and depressive disease influence each other (path 6 and 7). And finally, depressive and cardiovascular diseases affect productivity loss (paths 8 and 9).
도 8에는 선행 질환 인자로서 비만을 나타냈으나, 비만 외 다른 선행 질환 인자에 대해서도 동일한 방식으로 생산성 손실도 예측 모델에서 작동하는 모든 경로를 나타낼 수 있다. 또한, 선행 질환 인자 외에도 흡연이나 음주 등 건강 영향 인자에 대해서도 마찬가지로 생산성 손실도 예측 모델에서 작동하는 모든 경로를 나타낼 수 있다. 즉, 본 발명에 따른 생산성 손실도 예측모델은 구성원의 발병 위험 인자가 다른 발병 위험 인자 또는 주요 질환 인자에 영향을 미쳐, 최종적으로 조직의 생산성 손실에 영향을 미치는 모든 경로를 반영함으로써, 구성원의 건강 상태와 조직의 생산성 손실의 관계를 유기적으로 도출할 수 있다.Although obesity is shown as an antecedent disease factor in FIG. 8 , all pathways operating in the productivity loss prediction model can be shown in the same manner for other antecedent disease factors other than obesity. Also, in addition to the antecedent disease factors, productivity loss can also represent all pathways operating in the predictive model for health-affecting factors such as smoking and drinking. That is, the productivity loss prediction model according to the present invention reflects all pathways in which a member's disease risk factors affect other disease risk factors or major disease factors, ultimately affecting the tissue productivity loss, thereby improving the health of the members. The relationship between state and organizational productivity loss can be derived organically.
다음, 도 9에 나타낸 바와 같이, 생산성 손실도 예측모델을 도출하는 단계(S400')는, 발병 위험 인자로 인한 주요 질환 인자의 순발병률 변화의 총합을 산출하는 단계(S410'), 주요 질환 인자별 유병률과 순발병률 변화의 총합으로부터 발병 위험 인자가 주요 질환 인자의 유병률에 미치는 영향을 산출하는 단계(S420'), 발병 위험 인자가 주요 질환 인자의 유병률에 미치는 영향으로부터 발병 위험 인자가 생산성 손실에 미치는 영향의 가중치를 산출하는 단계(S430'), 발병 위험 인자가 생산성 손실에 미치는 영향의 가중치로부터 발병 위험 지수를 산출하는 단계(S440')를 더 포함할 수 있다.Next, as shown in FIG. 9 , the step of deriving a productivity loss prediction model (S400') is a step of calculating the sum of changes in the net incidence of major disease factors due to the onset risk factors (S410'), the major disease factors The step of calculating the effect of the onset risk factor on the prevalence of the major disease factor from the sum of the changes in the star prevalence and the net incidence rate (S420'). From the effect of the onset risk factor on the prevalence of the major disease factor, the onset risk factor affects productivity loss. The method may further include calculating the weight of the influence (S430') and calculating the risk index from the weight of the influence of the disease risk factor on the productivity loss (S440').
먼저, 발병 위험 인자로 인한 주요 질환 인자의 순발병률 변화의 총합을 산출한다(S410'). 발병 위험 인자로 인한 주요 질환 인자의 순발병률의 변화의 총합은, 전술한 바와 같이 발병 위험 인자가 생산성 손실에 영향을 미치는 모든 경로의 변화의 총합을 의미할 수 있다. 발병 위험 인자로 인한 주요 질환 인자의 순발병률 변화의 총합은 이하의 수학식 7로 산출될 수 있다.First, the sum of changes in the net incidence of major disease factors due to the onset risk factors is calculated (S410'). The sum of changes in net incidence of major disease factors due to risk factors may mean the sum of changes in all pathways in which onset risk factors affect productivity loss, as described above. The sum of changes in the net incidence of major disease factors due to the onset risk factors may be calculated by Equation 7 below.
[수학식 7][Equation 7]
발병 위험 인자 j로 인한 주요 질환 인자 i의 순발병률의 변화의 총합
Figure PCTKR2021000637-appb-I000021
Sum of changes in net incidence of major disease factor i due to risk factor j
Figure PCTKR2021000637-appb-I000021
Figure PCTKR2021000637-appb-I000022
Figure PCTKR2021000637-appb-I000022
여기서 i는 주요 질환 인자이고, j는 발병 위험 인자이고, nji는 발병 위험 인자 j에 의한 주요 질환 인자 i의 순발병률이고, pj는 발병 위험 인자 j의 유병률이고,
Figure PCTKR2021000637-appb-I000023
는 주요 질환 인자 i를 갖지 않는 구성원 중 발병 위험 인자 j를 갖지 않는 구성원의 주요 질환 인자 i의 발병률이고, ORi는 발병률(incidence rate)에 대한 오즈비(odds ratio)로서
Figure PCTKR2021000637-appb-I000024
는 발병 위험 인자 j의 주요 질환 인자 i에 대한 발병률의 오즈비(odds ratio)이고,
Figure PCTKR2021000637-appb-I000025
는 주요 질환 인자 i를 갖는 구성원 중 발병 위험 인자 j를 갖지 않는 구성원의 주요 질환 인자 i의 회복률이고, ORr는 회복률(recovery rate)에 대한 오즈비로서
Figure PCTKR2021000637-appb-I000026
는 발병 위험 인자 j의 주요 질환 인자 i에 대한 회복률의 오즈비이고, pi는 주요 질환 인자 i의 유병률이다. 또한, 오즈비는 요인 대조 연구에 있어서 독립 변수와 종속 변수의 인과 관계를 파악하기 위한 값으로서, 본 발명에서는 독립 변수를 발병 위험 인자로 설정하고 종속 변수를 주요 질환 인자로 설정할 수 있다. 본 발명의 다른 실시예에 따른 조직 건강 지수 평가 방법에 사용되는 오즈비의 일 예를 도 10에 나타낸다.
where i is the major disease factor, j is the risk factor for the onset, nji is the net incidence of the major disease factor i by the risk factor j, p j is the prevalence of the risk factor j,
Figure PCTKR2021000637-appb-I000023
is the incidence of major disease factor i among members without major disease factor i among members without risk factor j, OR i is the odds ratio to the incidence rate
Figure PCTKR2021000637-appb-I000024
is the odds ratio of the incidence rate for the major disease factor i of the risk factor j,
Figure PCTKR2021000637-appb-I000025
is the recovery rate of the major disease factor i of members without the risk factor j among members with the major disease factor i, and OR r is the odds ratio for the recovery rate
Figure PCTKR2021000637-appb-I000026
is the odds ratio of the recovery rate for the major disease factor i of the onset risk factor j, and pi is the prevalence of the major disease factor i. In addition, the odds ratio is a value for determining the causal relationship between the independent variable and the dependent variable in a factor control study. In the present invention, the independent variable can be set as an onset risk factor and the dependent variable can be set as a major disease factor. An example of an odds ratio used in a method for evaluating a tissue health index according to another embodiment of the present invention is shown in FIG. 10 .
즉, 발병 위험 인자로 인한 주요 질환 인자의 순발병률의 변화의 총합은, 생산성 손실에 영향을 미치는 주요 질환 인자의 발병률의 변화에 대한 발병 위험 인자의 영향을 의미할 수 있다.That is, the sum of the changes in the net incidence of major disease factors due to the onset risk factors may mean the effect of the onset risk factors on the changes in the incidence rates of the major disease factors affecting productivity loss.
전술한 바와 같이 발명 위험 인자에는 선행 질환 인자와 건강 영향 인자가 포함된다. 따라서, 상기 수학식 7에서 발병 위험 인자를 선행 질환 인자 또는 건강 영향 인자로 대체하여, 선행 질환 인자로 인한 주요 질환 인자의 순발병률의 변화의 총합 또는 건강 영향 인자로 인한 주요 질환 인자의 순발병률의 변화의 총합을 각각 산출할 수도 있다. 이 경우, 선행 질환 인자는 k, 건강 영향 인자는 l로 나타낼 수 있다.As described above, the risk factors for invention include antecedent disease factors and health-influencing factors. Therefore, by replacing the onset risk factor with the preceding disease factor or health-influencing factor in Equation 7, the sum of changes in the net incidence rate of the major disease factor due to the preceding disease factor or the net incidence rate of the major disease factor due to the health-influencing factor It is also possible to calculate the sum of the changes individually. In this case, the antecedent disease factor may be expressed as k, and the health influence factor may be expressed as l.
한편, 상기 수학식 7은 이하의 수학식 8로 유도될 수 있다. Meanwhile, Equation 7 can be derived from Equation 8 below.
[수학식 8][Equation 8]
Figure PCTKR2021000637-appb-I000027
Figure PCTKR2021000637-appb-I000027
Figure PCTKR2021000637-appb-I000028
Figure PCTKR2021000637-appb-I000028
Figure PCTKR2021000637-appb-I000029
Figure PCTKR2021000637-appb-I000029
Figure PCTKR2021000637-appb-I000030
Figure PCTKR2021000637-appb-I000030
Figure PCTKR2021000637-appb-I000031
Figure PCTKR2021000637-appb-I000031
Figure PCTKR2021000637-appb-I000032
Figure PCTKR2021000637-appb-I000032
Figure PCTKR2021000637-appb-I000033
Figure PCTKR2021000637-appb-I000033
Figure PCTKR2021000637-appb-I000034
Figure PCTKR2021000637-appb-I000034
Figure PCTKR2021000637-appb-I000035
Figure PCTKR2021000637-appb-I000035
Figure PCTKR2021000637-appb-I000036
Figure PCTKR2021000637-appb-I000036
여기서, ni는 주요 질환 인자 i의 순발병률이고, Ii는 주요 질환 인자 i의 발병자이고, Ri는 주요 질환 인자 i의 회복자이고, P는 총 인구이고, Pi는 주요 질환 인자 i의 유병자이고, ii는 주요 질환 인자 i의 발병률이고, ri는 주요 질환 인자 i의 회복률이고,
Figure PCTKR2021000637-appb-I000037
는 초기값, '는 변화된 값을 의미한다.
where ni is the net incidence of major disease factor i, Ii is the incidence of major disease factor i, Ri is the recoverer of major disease factor i, P is the total population, Pi is the prevalence of major disease factor i, and , i i is the incidence of major disease factor i, ri is the recovery rate of major disease factor i,
Figure PCTKR2021000637-appb-I000037
is the initial value, and ' means the changed value.
다음, 주요 질환 인자별 유병률과 순발병률 변화의 총합으로부터 발병 위험 인자가 주요 질환 인자의 유병률에 미치는 영향을 산출한다(S420'). 발병 위험 인자가 주요 질환 인자의 유병률에 미치는 영향은 이하의 수학식 9로 산출될 수 있다.Next, the effect of the onset risk factor on the prevalence of the major disease factor is calculated from the sum of the changes in the prevalence and net incidence for each major disease factor (S420'). The effect of the onset risk factors on the prevalence of major disease factors may be calculated by Equation 9 below.
[수학식 9][Equation 9]
발병 위험 인자 j가 주요 질환 인자 i의 유병률에 미치는 영향Effect of risk factor j on prevalence of major disease factor i
Figure PCTKR2021000637-appb-I000038
Figure PCTKR2021000637-appb-I000038
즉, 발병 위험 인자가 주요 질환 인자의 유병률에 미치는 영향은 발병 위험 인자로 인해 주요 질환 인자가 새롭게 발병된 사건으로 표현될 수 있다.That is, the effect of the onset risk factor on the prevalence of the major disease factor may be expressed as an event in which the major disease factor is newly onset due to the onset risk factor.
다음, 발병 위험 인자가 주요 질환 인자의 유병률에 미치는 영향으로부터 발병 위험 인자가 생산성 손실에 미치는 영향의 가중치를 산출한다(S430'). 발병 위험 인자가 생산성 손실에 미치는 영향의 가중치는 이하의 수학식 10으로 산출될 수 있다.Next, the weight of the effect of the onset risk factor on the productivity loss is calculated from the effect of the onset risk factor on the prevalence of the major disease factor (S430'). The weight of the effect of the disease risk factor on productivity loss may be calculated by Equation 10 below.
[수학식 10][Equation 10]
발병 위험 인자 j가 생산성 손실에 미치는 영향의 가중치 werTLPj Weight of the effect of risk factor j on productivity loss werTLP j
Figure PCTKR2021000637-appb-I000039
Figure PCTKR2021000637-appb-I000039
여기서 LPi는 상기 수학식 1에서 도출된, 주요 질환 인자 i로 인한 생산성 손실 영향도를 의미한다.Here, LPi denotes the effect on productivity loss due to the major disease factor i, derived from Equation 1 above.
다음, 발병 위험 인자가 생산성 손실에 미치는 영향의 가중치로부터 발병 위험 지수를 산출한다(S440'). 발병 위험 지수는 이하의 수학식 11로 산출될 수 있다.Next, the disease risk index is calculated from the weight of the effect of the disease risk factor on the productivity loss (S440'). The incidence risk index may be calculated by Equation 11 below.
[수학식 11][Equation 11]
발병 위험 지수
Figure PCTKR2021000637-appb-I000040
risk index
Figure PCTKR2021000637-appb-I000040
발병 위험 지수는 발병 위험 인자가 생산성 손실에 미치는 영향의 가중치와 발병 위험 인자의 유병률을 고려한 값으로서, 발병 위험 인자가 주요 질환 인자에 영향을 미쳐 최종적으로 조직의 생산성 손실을 유발할 수 있는 잠재적인 위험 요인을 정량화하여 나타내는 지표이다. 이를 바탕으로 구성원의 현재 건강 상태를 바탕으로 조직의 잠재적인 생산성 손실 위험을 예측할 수 있다. 또한, 전술한 바와 같이 발병 위험 인자는 선행 질환 인자와 건강 영향 인자를 모두 포함하며, 선행 질환 인자를 기초로 한 선행 질환 위험 지수와 건강 영향 인자를 기초로 한 건강 영향 위험 지수를 각각 산출할 수도 있다.The onset risk index is a value that considers the weight of the effect of the onset risk factor on the loss of productivity and the prevalence of the onset risk factor. The potential risk that the onset risk factor can affect the major disease factors and ultimately cause a loss of tissue productivity. It is an indicator that quantifies and indicates factors. Based on this, it is possible to predict the potential risk of loss of productivity in the organization based on the current health status of the members. In addition, as described above, the onset risk factors include both antecedent disease factors and health-influencing factors, and the antecedent disease risk index based on the antecedent disease factors and the health-affecting risk index based on the health-influencing factors may be calculated, respectively. there is.
또한, 전술한 바와 같이, 요인 대조 연구 정보를 포함하는 데이터베이스 내에는 주요 질환 인자의 유병률 등에 관한 정보가 조직별로 카테고리화되어 있을 수 있다. 이를 바탕으로 조직 간 생산성 손실도와 발병 위험 지수를 시각화하여 그래프로 나타낼 수 있다.In addition, as described above, in the database including the factor control study information, information on the prevalence of major disease factors, etc. may be categorized for each organization. Based on this, the degree of productivity loss between tissues and the risk index of disease can be visualized and expressed as a graph.
구체적으로, 주요 질환 인자에 의한 생산성 손실이 발생하지 않은 경우(즉, Per LPm = 0를 기준으로, 산출된 해당 조직의 생산성 손실도를 표준 점수화하여 이를 절대 생산성 손실도로 나타낼 수 있다. 또한, 요인 대조 연구 정보를 포함하는 데이터베이스 내의 다른 조직의 절대 생산성 손실도의 최댓값과 최솟값을 기준으로, 산출된 해당 조직의 생산성 손실도를 표준 점수화하여 이를 상대 생산성 손실도로 나타낼 수 있다.Specifically, when productivity loss due to major disease factors does not occur (that is, based on Per LPm = 0, the calculated loss of productivity of the corresponding tissue is scored as a standard score and this can be expressed as an absolute loss of productivity. Based on the maximum and minimum values of the absolute productivity loss of other organizations in the database including the control study information, the calculated productivity loss degree of the corresponding organization may be standardized and expressed as a relative productivity loss degree.
발병 위험 지수에 대해서도 동일한 방법이 적용될 수 있다. 즉, 주요 질환 인자에 의한 생산성 손실이 발생하지 않은 경우를 기준으로, 산출된 해당 조직의 발병 위험 지수를 표준 점수화하여 이를 절대 발병 위험 지수로 나타낼 수 있다. 또한, 요인 대조 연구 정보를 포함하는 데이터베이스 내의 다른 조직의 절대 발병 위험 지수의 최댓값과 최솟값을 기준으로, 산출된 해당 조직의 발병 위험 지수를 표준 점수화하여 이를 상대 발병 위험 지수로 나타낼 수 있다.The same method can be applied to the incidence risk index. That is, based on a case in which productivity loss due to major disease factors does not occur, the calculated disease risk index of the corresponding tissue may be standardized and expressed as an absolute disease risk index. In addition, based on the maximum and minimum values of the absolute risk indices of other tissues in the database including factor control research information, the calculated risk index of the disease may be standardized and expressed as a relative risk index.
다음, 도 11을 참조하여 본 발명의 또 다른 실시예에 따른 조직 건강 지수 평가 방법을 설명한다.Next, a tissue health index evaluation method according to another embodiment of the present invention will be described with reference to FIG. 11 .
도 11은 조직 간 생산성 손실도와 발병 위험 지수를 비교하는 그래프로서, 도 11(a)는 절대 생산성 손실도와 절대 발병 위험 지수를 나타내고, 도 11(b)는 상대 생산성 손실도와 상대 발병 위험 지수를 나타낸다. 도 11에는 조직 A, B, C와 요인 대조 연구 정보를 포함하는 데이터베이스 내의 전체 조직의 생산성 손실도와 발병 위험 지수를 각각 나타낸다. 참고로, 도 11에 나타낸 절대 생산성 손실도, 상대 생산성 손실도, 절대 발병 위험 지수 및 상대 발병 위험 지수는 각각 표준 점수화된 값으로서, 해당 조직의 현재 상태를 직관적으로 나타내기 위해 값이 클수록 생산성 손실도 또는 발병 위험 지수가 낮은 것으로 나타냈다(즉, 도 11에서 우측 상단에 가까울수록 생산성 손실이 낮음).11 is a graph comparing the degree of productivity loss and the incidence risk index between tissues, and FIG. 11 ( a ) shows the absolute productivity loss degree and the absolute incidence risk index, and FIG. 11 ( b ) shows the relative productivity loss degree and the relative incidence risk index. . 11 shows the productivity loss and disease risk index of the entire organization in the database including organization A, B, and C and factor control study information, respectively. For reference, the absolute productivity loss, relative productivity loss, absolute disease risk index, and relative disease risk index shown in FIG. 11 are each standard-scored values, and in order to intuitively represent the current state of the tissue, the greater the value, the greater the productivity loss. The degree or risk index was shown to be low (ie, the closer to the upper right corner in FIG. 11, the lower the productivity loss).
구체적으로, 도 11(a)에 나타내는 바와 같이, 조직 A는 절대 생산성 손실도가 낮아 구성원의 현재 건강 상태에 따른 생산성 손실은 높지만, 절대 발병 위험 지수는 평균 이상으로서 미래의 생산성 손실은 보다 낮아질 것으로 예측된다. 또한 조직 B는 절대 생산성 손실도와 절대 발병 위험 지수 모두 평균보다 낮다. 또한 조직 C는 절대 생산성 손실도와 절대 발병 위험 지수 모두 평균보다 높아, 현재뿐만 아니라 미래에도 낮은 생산성 손실이 예측된다.Specifically, as shown in Figure 11 (a), tissue A has a low absolute productivity loss, so productivity loss according to the member's current health status is high, but the absolute risk index is higher than the average, so future productivity loss will be lower. predicted In addition, organization B is below average in both absolute productivity loss and absolute risk index. In addition, in tissue C, both the absolute productivity loss and absolute risk index are higher than the average, so low productivity loss is predicted not only now but also in the future.
또한, 도 11(b)에 나타내는 바와 같이, 조직 A는 타사 대비 가장 낮은 상대 생산성 손실도를 보이지만 상대 발병 위험 지수가 조직 B보다 높아, 추후 조직 B보다 생산성 손실이 낮아질 것으로 예측된다. 반대로 조직 B는 타사 대비 가장 낮은 상대 발병 위험 지수를 보여 추후 타사보다 생산성 손실이 더 높아질 것으로 예측된다. 반면, 조직 C는 타사 대비 상대 생산성 손실도 및 상대 발병 위험 지수가 모두 높아, 현재뿐만 아니라 미래에도 타사 대비 낮은 생산성 손실을 유지할 것으로 예측된다. 이와 같이, 생산성 손실도와 발병 위험 지수에 대해 각각 절대값과 상대값을 산출함으로써, 구성원의 현재 건강 상태를 바탕으로 해당 조직의 현재의 생산성 손실도와 잠재적인 생산성 손실 위험을 타사와 비교하여 파악할 수 있다.In addition, as shown in FIG. 11( b ), tissue A shows the lowest relative productivity loss compared to other companies, but has a higher relative risk index than tissue B, and is predicted to have lower productivity loss than tissue B in the future. Conversely, organization B shows the lowest relative risk index compared to other companies, so it is predicted that productivity loss will be higher than other companies in the future. On the other hand, organization C has both a higher relative productivity loss and a higher relative risk index than other companies, so it is expected to maintain a lower productivity loss compared to other companies now and in the future. In this way, by calculating the absolute and relative values for the productivity loss degree and the disease risk index, respectively, the current productivity loss degree and the potential productivity loss risk of the organization can be compared with those of other companies based on the member's current health status. .
다른 실시예로, 요인 대조 연구 정보를 포함하는 데이터베이스를 바탕으로, 산출된 생산성 손실도와 발병 위험 지수를 카테고리화할 수 있다. 예를 들어, 전술한 바와 같이 만 40세를 기준으로 성별에 따라 4개의 인구 집단으로 구성원을 구분하고, 각각의 인구 집단별로 발병 위험 지수를 개별적으로 산출할 수 있다. In another embodiment, based on a database including factor control study information, the calculated productivity loss and disease risk index may be categorized. For example, as described above, the members may be divided into four population groups according to gender based on the age of 40, and the disease risk index may be individually calculated for each population group.
또 다른 실시예로, 조직 내에서 해당 인구 집단별 구성원의 수를 고려하여 가중 평균을 산출하고, 이를 발병 위험 지수로 설정할 수도 있다. 이를 통해 조직 내의 인구 집단별로 건강 상태를 파악하고 잠재적인 생산성 손실 위험을 예측할 수 있다. 즉, 성별 및 연령에 따라 조직 내에서 건강 상태 및 생산성 손실이 취약한 집단을 파악할 수 있다. 이는 생산성 손실도에 대해서도 동일하게 적용할 수 있다.In another embodiment, a weighted average may be calculated in consideration of the number of members for each corresponding population group within an organization, and this may be set as an outbreak risk index. This allows us to understand the health status of each population group within an organization and predict the potential risk of loss of productivity. That is, it is possible to identify a group in an organization that is vulnerable to loss of health and productivity according to gender and age. This can be equally applied to the degree of productivity loss.
전술한 바와 같이, 본 발명의 실시예들에 따른 조직 건강 지수 평가 방법 및 이를 실행하는 컴퓨터 프로그램은, 요인 대조 연구 정보를 포함하는 데이터베이스로부터 사전에 설정된 복수의 주요 질환 인자에 관한 상기 구성원의 상기 주요 질환 인자별 유병률 정보와, 상기 주요 질환 인자 각각에 따른 상기 구성원의 근태 정보를 제공받아, 상기 주요 질환 인자별 유병률 정보와 상기 구성원의 근태 정보를 이용하여 상기 조직의 생산성 손실도를 예측하는 생산성 손실도 예측모델을 도출할 수 있다.As described above, the tissue health index evaluation method and the computer program executing the same according to the embodiments of the present invention, the major disease factors of the member in relation to a plurality of major disease factors preset from a database including factor control study information Productivity loss for receiving prevalence information for each disease factor and time and attendance information of the member according to each of the major disease factors, and predicting the degree of productivity loss of the tissue using the prevalence information for each major disease factor and time and attendance information of the member It is also possible to derive a predictive model.
또한, 본 발명의 실시예들에 따른 조직 건강 지수 평가 방법 및 이를 실행하는 컴퓨터 프로그램은 구성원의 건강 상태를 객관적으로 파악할 수 있는 데이터와 구성원의 근무 환경을 파악할 수 있는 데이터를 모두 이용하여 생산성 손실도 예측모델을 도출함으로써, 구성원의 건강 상태와 조직의 생산성 손실의 관계를 유기적으로 파악할 수 있는 조직 건강 지수를 산출할 수 있으며, 이를 통해 조직의 현재 생산성 손실도를 파악하고, 잠재적인 생산성 손실 위험을 예측할 수 있다.In addition, the organizational health index evaluation method and the computer program executing the same according to embodiments of the present invention use both data that can objectively determine the health status of a member and data that can identify the member's working environment, so that productivity loss is also By deriving a predictive model, it is possible to calculate the organizational health index that can organically determine the relationship between the health status of members and the loss of productivity of the organization. predictable.
이상 설명된 본 발명에 따른 실시예는 컴퓨터 상에서 다양한 구성요소를 통하여 실행될 수 있는 컴퓨터 프로그램의 형태로 구현될 수 있으며, 이와 같은 컴퓨터 프로그램은 컴퓨터로 판독 가능한 매체에 기록될 수 있다. 이때, 매체는 컴퓨터로 실행 가능한 프로그램을 저장하는 것일 수 있다. 매체의 예시로는, 하드 디스크, 플로피 디스크 및 자기 테이프와 같은 자기 매체, CD-ROM 및 DVD와 같은 광기록 매체, 플롭티컬 디스크(floptical disk)와 같은 자기-광 매체(magneto-optical medium), 및 ROM, RAM, 플래시 메모리 등을 포함하여 프로그램 명령어가 저장되도록 구성된 것이 있을 수 있다. The embodiment according to the present invention described above may be implemented in the form of a computer program that can be executed through various components on a computer, and such a computer program may be recorded in a computer-readable medium. In this case, the medium may be to store a program executable by a computer. Examples of the medium include a hard disk, a magnetic medium such as a floppy disk and a magnetic tape, an optical recording medium such as CD-ROM and DVD, a magneto-optical medium such as a floppy disk, and those configured to store program instructions, including ROM, RAM, flash memory, and the like.
한편, 상기 컴퓨터 프로그램은 본 발명을 위하여 특별히 설계되고 구성된 것이거나 컴퓨터 소프트웨어 분야의 통상의 기술자에게 공지되어 사용 가능한 것일 수 있다. 컴퓨터 프로그램의 예에는, 컴파일러에 의하여 만들어지는 것과 같은 기계어 코드뿐만 아니라 인터프리터 등을 사용하여 컴퓨터에 의해서 실행될 수 있는 고급 언어 코드도 포함될 수 있다.Meanwhile, the computer program may be specially designed and configured for the present invention, or may be known and available to those skilled in the art of computer software. Examples of the computer program may include not only machine language codes such as those generated by a compiler, but also high-level language codes that can be executed by a computer using an interpreter or the like.
본 발명에서 설명하는 특정 실행들은 일 실시예들로서, 어떠한 방법으로도 본 발명의 범위를 한정하는 것은 아니다. 명세서의 간결함을 위하여, 종래 전자적인 구성들, 제어 시스템들, 소프트웨어, 상기 시스템들의 다른 기능적인 측면들의 기재는 생략될 수 있다. 또한, 도면에 도시된 구성요소들 간의 선들의 연결 또는 연결 부재들은 기능적인 연결 및/또는 물리적 또는 회로적 연결들을 예시적으로 나타낸 것으로서, 실제 장치에서는 대체 가능하거나 추가의 다양한 기능적인 연결, 물리적인 연결, 또는 회로 연결들로서 나타내어질 수 있다. 또한, "필수적인", "중요하게" 등과 같이 구체적인 언급이 없다면 본 발명의 적용을 위하여 반드시 필요한 구성 요소가 아닐 수 있다.The specific implementations described in the present invention are only examples and do not limit the scope of the present invention in any way. For brevity of the specification, descriptions of conventional electronic components, control systems, software, and other functional aspects of the systems may be omitted. In addition, the connection or connection members of the lines between the components shown in the drawings illustratively represent functional connections and/or physical or circuit connections, and in an actual device, various functional connections, physical connections that are replaceable or additional may be referred to as connections, or circuit connections. In addition, unless there is a specific reference such as "essential" or "importantly", it may not be a necessary component for the application of the present invention.
따라서, 본 발명의 사상은 상기 설명된 실시예에 국한되어 정해져서는 아니 되며, 후술하는 청구범위뿐만 아니라 이 청구범위와 균등한 또는 이로부터 등가적으로 변경된 모든 범위는 본 발명의 사상의 범주에 속한다고 할 것이다Therefore, the spirit of the present invention should not be limited to the above-described embodiments, and not only the claims described below, but also all ranges equivalent to or changed from these claims belong to the scope of the spirit of the present invention. will do
본 발명은 조직 건강 지수 평가 방법 및 이를 실행하는 컴퓨터 프로그램 관련 산업에 이용될 수 있다.The present invention can be applied to a method for evaluating a tissue health index and a computer program-related industry for executing the same.

Claims (17)

  1. 구성원의 건강 상태에 따른 조직의 건강 지수를 평가하는 조직 건강 지수 평가 방법으로서,An organizational health index evaluation method for evaluating an organization's health index according to a member's health status,
    요인 대조 연구 정보를 포함하는 데이터베이스로부터 사전에 설정된 복수의 주요 질환 인자에 관한 상기 구성원의 상기 주요 질환 인자별 유병률 정보를 제공받는 단계;receiving, from a database including factor control study information, the prevalence information for each of the major disease factors of the member with respect to a plurality of preset major disease factors;
    상기 주요 질환 인자 각각에 따른 상기 구성원의 근태 정보를 제공받는 단계; 및receiving time and attendance information of the member according to each of the major disease factors; and
    상기 주요 질환 인자별 유병률 정보와 상기 구성원의 근태 정보를 이용하여 상기 조직의 생산성 손실도를 예측하는 생산성 손실도 예측모델을 도출하는 단계;를 포함하는, 조직 건강 지수 평가 방법.Deriving a productivity loss prediction model for predicting the productivity loss of the tissue by using the prevalence information for each major disease factor and the attendance information of the member; including; tissue health index evaluation method.
  2. 제1 항에 있어서, The method of claim 1,
    상기 주요 질환 인자 각각에 따른 상기 구성원의 근태 정보는 상기 구성원의 문진 데이터를 이용하여 제공받는, 조직 건강 지수 평가 방법.The member's attendance information according to each of the major disease factors is provided by using the member's questionnaire data, a tissue health index evaluation method.
  3. 제2 항에 있어서,3. The method of claim 2,
    상기 생산성 손실도 예측모델을 도출하는 단계는, The step of deriving the productivity loss prediction model is,
    상기 구성원의 문진 데이터로부터 상기 주요 질환 인자별 생산성 손실 영향도를 산출하는 단계; 및calculating an effect on productivity loss for each major disease factor from the member's questionnaire data; and
    상기 주요 질환 인자별 유병률 정보와 상기 주요 질환 인자별 생산성 손실 영향도를 이용하여 상기 생산성 손실도를 예측하는 생산성 손실도 예측모델을 도출하는 단계;를 포함하는, 조직 건강 지수 평가 방법.Deriving a productivity loss prediction model for predicting the productivity loss by using the prevalence information for each major disease factor and the productivity loss effect for each major disease factor; including; tissue health index evaluation method.
  4. 제3 항에 있어서, 4. The method of claim 3,
    상기 문진 데이터는 상기 주요 질환 인자로 인한 구성원의 엡센티즘(Absenteeism)과 프리젠티즘(Presenteeism)에 관한 데이터이며, 상기 엡센티즘은 상기 주요 질환 인자로 인한 구성원의 결근 또는 조퇴 시간이고, 상기 프리젠티즘은 상기 주요 질환 인자로 인한 구성원의 생산성 손실 정도인, 조직 건강 지수 평가 방법.The questionnaire data is data on Absenteeism and Presenteeism of a member due to the major disease factor, wherein the Absenteeism is the absence or early departure time of the member due to the major disease factor, and the presentation Tism is the degree of loss of productivity of members due to the major disease factor, tissue health index evaluation method.
  5. 제4 항에 있어서,5. The method of claim 4,
    상기 주요 질환 인자별 생산성 손실 영향도 및 상기 생산성 손실도는 각각 이하의 식 (1) 및 식 (2)로 산출되는, 조직 건강 지수 평가 방법.The productivity loss effect for each major disease factor and the productivity loss degree are calculated by the following Equations (1) and (2), respectively, a tissue health index evaluation method.
    주요 질환 인자 i로 인한 생산성 손실 영향도
    Figure PCTKR2021000637-appb-I000041
    Effect of productivity loss due to major disease factor i
    Figure PCTKR2021000637-appb-I000041
    조직 M의 생산성 손실도
    Figure PCTKR2021000637-appb-I000042
    Loss of productivity in organization M
    Figure PCTKR2021000637-appb-I000042
    단, 여기서 LPAi는 (주요 질환 인자 i로 인한 사전에 설정된 제1 기간 동안의 엡센티즘 시간)/(상기 제1 기간 동안의 총 근무시간)이고, LPPi는 주요 질환 인자 i로 인한 상기 제1 기간 동안의 프리젠티즘 정도이고, LPAi 및 LPPi는
    Figure PCTKR2021000637-appb-I000043
    이고, pim는 조직 m의 주요 질환 인자 i의 유병률임.
    with the proviso that LPAi is (epcentism time for a first preset period due to major disease factor i)/(total working hours during said first period), and LPPi is said first time period due to major disease factor i degree of presentation during the period, and LPAi and LPPi are
    Figure PCTKR2021000637-appb-I000043
    , and p im is the prevalence of major disease factor i in tissue m.
  6. 제5 항에 있어서,6. The method of claim 5,
    상기 생산성 손실도 예측모델을 도출하는 단계는,The step of deriving the productivity loss prediction model is,
    상기 주요 질환 인자별 생산성 손실 영향도를 상기 주요 질환 인자의 상기 생산성 손실도에 대한 절대 영향도로 설정하고, 상기 주요 질환 인자별 생산성 손실 영향도와 상기 조직의 전체 구성원 수 대비 상기 주요 질환 인자를 갖는 구성원 수의 비율의 곱을 상기 주요 질환 인자의 상기 생산성 손실도에 대한 상대 영향도로 설정하는 단계;를 더 포함하는, 조직 건강 지수 평가 방법.The effect of the productivity loss for each major disease factor is set as an absolute effect on the productivity loss of the major disease factor, and the member having the major disease factor relative to the effect of the major disease factor on the productivity loss and the total number of members of the organization. Setting the product of the ratio of the number to the relative influence of the major disease factor on the productivity loss; further comprising, a tissue health index evaluation method.
  7. 제5 항에 있어서,6. The method of claim 5,
    상기 생산성 손실도 예측모델을 도출하는 단계는,The step of deriving the productivity loss prediction model is,
    생산성 손실이 발생하지 않은 경우를 기준으로 상기 생산성 손실도를 표준 점수화하여 상기 조직의 절대 생산성 손실도를 설정하고, 상기 요인 대조 연구 정보를 포함하는 데이터베이스 내의 전체 조직의 상기 생산성 손실도의 최댓값 및 최솟값을 기준으로 상기 생산성 손실도를 표준 점수화하여 상기 조직의 상대 생산성 손실도를 설정하는 단계;를 더 포함하는, 조직 건강 지수 평가 방법.The absolute productivity loss degree of the organization is set by standardizing the productivity loss degree on the basis of a case in which no productivity loss occurs, and the maximum and minimum values of the productivity loss degree of the entire organization in the database including the factor control study information. Setting the relative productivity loss of the tissue by standardizing the productivity loss degree based on the; further comprising, the tissue health index evaluation method.
  8. 제5 항에 있어서,6. The method of claim 5,
    상기 생산성 손실도 예측모델을 도출하는 단계는,The step of deriving the productivity loss prediction model is,
    총 생산성 손실, 총 생산 시간 손실 및 총 생산 임금 손실을 각각 이하의 식 (3) 내지 식 (5)로 산출하는 단계;를 더 포함하는, 조직 건강 지수 평가 방법.Calculating the total productivity loss, the total production time loss, and the total production wage loss by the following Equations (3) to (5), respectively; further comprising, an organizational health index evaluation method.
    조직 m의 총 생산 손실
    Figure PCTKR2021000637-appb-I000044
    total loss of production of tissue m
    Figure PCTKR2021000637-appb-I000044
    조직 m의 총 생산 시간 손실
    Figure PCTKR2021000637-appb-I000045
    total production time loss of tissue m
    Figure PCTKR2021000637-appb-I000045
    조직 m의 총 생산 임금 손실
    Figure PCTKR2021000637-appb-I000046
    Total production wage loss of organization m
    Figure PCTKR2021000637-appb-I000046
    단, 여기서 Pm는 조직 m의 구성원 수이고, Tm는 조직 m의 평균 근로 시간이고, Wm는 조직 m의 평균 임금임.where Pm is the number of members of organization m, Tm is the average working hours of organization m, and Wm is the average wage of organization m.
  9. 제1 항에 있어서,The method of claim 1,
    상기 주요 질환 인자는 심뇌혈관 질환, 알러지성 질환, 호흡기 질환, 소화기 질환, 우울 질환 및 수면 질환을 포함하는, 조직 건강 지수 평가 방법.The major disease factors include cardiovascular disease, allergic disease, respiratory disease, digestive disease, depressive disease and sleep disease, tissue health index evaluation method.
  10. 제1 항에 있어서, The method of claim 1,
    상기 요인 대조 연구 정보를 포함하는 데이터베이스로부터 상기 주요 질환 인자에 영향을 미치는 사전에 설정된 복수의 발병 위험 인자에 관한 상기 구성원의 상기 발병 위험 인자 정보를 제공받는 단계;를 더 포함하고, Further comprising; receiving the risk factor information of the member with respect to a plurality of preset risk factors affecting the major disease factors from a database including the factor control study information;
    상기 생산성 손실도 예측모델을 도출하는 단계는, The step of deriving the productivity loss prediction model is,
    상기 발병 위험 인자 정보를 더 이용하여 상기 생산성 손실도 예측모델을 도출하는 단계인, 조직 건강 지수 평가 방법.The step of deriving the productivity loss predictive model further using the onset risk factor information, tissue health index evaluation method.
  11. 제10 항에 있어서, 11. The method of claim 10,
    상기 생산성 손실도 예측모델을 도출하는 단계는, The step of deriving the productivity loss prediction model is,
    상기 발병 위험 인자가 상기 생산성 손실에 영향을 미치는 모든 경로를 도출하고, 상기 경로의 개수에 따라 상기 발병 위험 인자가 상기 생산성 손실에 미치는 영향의 가중치를 산출하여 상기 생산성 손실도 예측모델을 도출하는, 조직 건강 지수 평가 방법.Deriving all pathways in which the onset risk factor affects the productivity loss, and calculating the weight of the impact of the onset risk factor on the productivity loss according to the number of pathways to derive the productivity loss prediction model, Methods for evaluating tissue health index.
  12. 제11 항에 있어서,12. The method of claim 11,
    상기 생산성 손실도 예측모델을 도출하는 단계는, The step of deriving the productivity loss prediction model is,
    상기 발병 위험 인자로 인한 상기 주요 질환 인자의 순발병률 변화의 총합을 산출하는 단계;calculating the sum of changes in net incidence of the major disease factors due to the onset risk factors;
    상기 주요 질환 인자별 유병률과 상기 순발병률 변화의 총합으로부터 상기 발병 위험 인자가 상기 주요 질환 인자의 유병률에 미치는 영향을 산출하는 단계;calculating an effect of the onset risk factor on the prevalence of the major disease factor from the sum of the change in the prevalence and the net incidence rate for each major disease factor;
    상기 발병 위험 인자가 상기 주요 질환 인자의 유병률에 미치는 영향으로부터 상기 발병 위험 인자가 상기 생산성 손실에 미치는 영향의 가중치를 산출하는 단계; 및calculating a weight of the effect of the onset risk factor on the productivity loss from the effect of the onset risk factor on the prevalence of the major disease factor; and
    상기 발병 위험 인자가 상기 생산성 손실에 미치는 영향의 가중치로부터 발병 위험 지수를 산출하는 단계;를 포함하는, 조직 건강 지수 평가 방법.Calculating an onset risk index from the weight of the effect of the onset risk factor on the productivity loss; Containing, a tissue health index evaluation method.
  13. 제12 항에 있어서,13. The method of claim 12,
    상기 발병 위험 인자로 인한 상기 주요 질환 인자의 순발병률 변화의 총합, 상기 발병 위험 인자가 상기 주요 질환 인자의 유병률에 미치는 영향, 상기 발병 위험 인자가 상기 생산성 손실에 미치는 영향의 가중치 및 상기 발병 위험 지수는 이하의 식 (6) 내지 (9)로 산출되는, 조직 건강 지수 평가 방법.The sum total of changes in the net incidence of the major disease factors due to the risk factors, the effect of the onset risk factors on the prevalence of the major disease factors, the weight of the effect of the onset risk factors on the productivity loss, and the risk index is calculated by the following formulas (6) to (9), the tissue health index evaluation method.
    발병 위험 인자 j로 인한 주요 질환 인자 i의 순발병률의 변화의 총합
    Figure PCTKR2021000637-appb-I000047
    Sum of changes in net incidence of major disease factor i due to risk factor j
    Figure PCTKR2021000637-appb-I000047
    Figure PCTKR2021000637-appb-I000048
    Figure PCTKR2021000637-appb-I000048
    발병 위험 인자 j가 주요 질환 인자 i의 유병률에 미치는 영향Effect of risk factor j on prevalence of major disease factor i
    Figure PCTKR2021000637-appb-I000049
    Figure PCTKR2021000637-appb-I000049
    발병 위험 인자 j가 생산성 손실에 미치는 영향의 가중치 werTLPj Weight of the effect of risk factor j on productivity loss werTLPj
    Figure PCTKR2021000637-appb-I000050
    Figure PCTKR2021000637-appb-I000050
    발병 위험 지수
    Figure PCTKR2021000637-appb-I000051
    risk index
    Figure PCTKR2021000637-appb-I000051
    단, 여기서 i는 주요 질환 인자이고, j는 발병 위험 인자이고, nji는 발병 위험 인자 j에 의한 주요 질환 인자 i의 순발병률이고, pj는 발병 위험 인자 j의 유병률이고,
    Figure PCTKR2021000637-appb-I000052
    는 주요 질환 인자 i를 갖지 않는 구성원 중 발병 위험 인자 j를 갖지 않는 구성원의 주요 질환 인자 i의 발병률이고,
    Figure PCTKR2021000637-appb-I000053
    는 발병 위험 인자 j의 주요 질환 인자 i에 대한 발병률의 오즈비(odds ratio)이고,
    Figure PCTKR2021000637-appb-I000054
    는 주요 질환 인자 i를 갖는 구성원 중 발병 위험 인자 j를 갖지 않는 구성원의 주요 질환 인자 i의 회복률이고,
    Figure PCTKR2021000637-appb-I000055
    는 발병 위험 인자 j의 주요 질환 인자 i에 대한 회복률의 오즈비이고, pi는 주요 질환 인자 i의 유병률임. 또한 상기 오즈비는 상기 요인 대조 연구 정보를 포함하는 데이터베이스로부터 산출됨.
    with the proviso that i is a major disease factor, j is an onset risk factor, n ji is the net incidence of the major disease factor i by the onset risk factor j, p j is the prevalence of the onset risk factor j,
    Figure PCTKR2021000637-appb-I000052
    is the incidence of major disease factor i among members without major disease factor i, without risk factor j,
    Figure PCTKR2021000637-appb-I000053
    is the odds ratio of the incidence rate for the major disease factor i of the risk factor j,
    Figure PCTKR2021000637-appb-I000054
    is the recovery rate of major disease factor i of members without risk factor j among members with major disease factor i,
    Figure PCTKR2021000637-appb-I000055
    is the odds ratio of the recovery rate for the major disease factor i of the onset risk factor j, and pi is the prevalence of the major disease factor i. In addition, the odds ratio is calculated from a database including the factor control study information.
  14. 제13 항에 있어서,14. The method of claim 13,
    상기 생산성 손실도 예측모델을 도출하는 단계는,The step of deriving the productivity loss prediction model is,
    생산성 손실이 발생하지 않은 경우를 기준으로 상기 발병 위험 지수를 표준 점수화하여 상기 조직의 절대 발병 위험 지수를 설정하고, 상기 요인 대조 연구 정보를 포함하는 데이터베이스 내의 전체 조직의 상기 발병 위험 지수의 최댓값과 최솟값을 기준으로 상기 발병 위험 지수를 표준 점수화하여 상기 조직의 상대 발병 위험 지수를 설정하는 단계;를 더 포함하는, 조직 건강 지수 평가 방법. Set the absolute risk index of the tissue by standardizing the onset risk index based on a case in which no productivity loss occurs, and the maximum and minimum values of the onset risk index of the entire organization in the database including the factor-controlled study information Setting the relative incidence risk index of the tissue by standardizing the onset risk index based on a; further comprising, a tissue health index evaluation method.
  15. 제12 항에 있어서,13. The method of claim 12,
    상기 발병 위험 인자는 상기 주요 질환 인자에 영향을 미치는 선행 질환 인자와, 상기 주요 질환 인자 또는 상기 선행 질환 인자에 영향을 미치는 건강 영향 인자를 포함하고,The risk factors for the onset include a prior disease factor affecting the major disease factor, and a health-influencing factor affecting the major disease factor or the preceding disease factor,
    상기 발병 위험 지수는 상기 선행 질환 인자에 의한 선행 질환 위험 지수와, 상기 건강 영향 인자에 의한 건강 영향 위험 지수를 포함하는, 조직 건강 지수 평가 방법.The onset risk index includes a prior disease risk index due to the preceding disease factor, and a health impact risk index due to the health influence factor, a tissue health index evaluation method.
  16. 제15 항에 있어서,16. The method of claim 15,
    상기 주요 질환 인자는 심뇌혈관 질환, 알러지성 질환, 호흡기 질환, 소화기 질환, 우울 질환 및 수면 질환을 포함하고,The major disease factors include cardiovascular diseases, allergic diseases, respiratory diseases, digestive diseases, depressive diseases and sleep diseases,
    상기 선행 질환 인자는 당뇨, 고혈압, 비만, 고콜레스테롤을 포함하고,The preceding disease factors include diabetes, hypertension, obesity, and high cholesterol,
    상기 건강 영향 인자는 흡연, 운동 부족, 일반 스트레스, 직무 스트레스, 음주을 포함하는, 조직 건강 지수 평가 방법.The health-influencing factors include smoking, lack of exercise, general stress, job stress, and drinking, organizational health index evaluation method.
  17. 컴퓨터를 이용하여 제1 항 내지 제16 항의 방법 중 어느 하나의 방법을 실행시키기 위하여 매체에 저장된 컴퓨터 프로그램.A computer program stored in a medium for executing the method of any one of claims 1 to 16 using a computer.
PCT/KR2021/000637 2020-01-16 2021-01-15 Group health index evaluation method and computer program for executing same WO2021145740A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020200006157A KR102320132B1 (en) 2020-01-16 2020-01-16 Method for evaluating organization health index and computer program for executing for the method
KR10-2020-0006157 2020-01-16

Publications (1)

Publication Number Publication Date
WO2021145740A1 true WO2021145740A1 (en) 2021-07-22

Family

ID=76863875

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2021/000637 WO2021145740A1 (en) 2020-01-16 2021-01-15 Group health index evaluation method and computer program for executing same

Country Status (2)

Country Link
KR (1) KR102320132B1 (en)
WO (1) WO2021145740A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240014239A (en) 2022-07-25 2024-02-01 (의) 삼성의료재단 Apparatus and method for managing corporate health

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017068831A (en) * 2015-09-30 2017-04-06 日通システム株式会社 Labor management system, labor management method and labor management program
JP2017170066A (en) * 2016-03-25 2017-09-28 東芝情報システム株式会社 Health management system and health management program
KR20190104500A (en) * 2019-09-02 2019-09-10 차의과학대학교 산학협력단 Disease Network Generating Method using Cohort and Computer Readable Record Medium thereof
JP2019185416A (en) * 2018-04-11 2019-10-24 アビームコンサルティング株式会社 Automatic calculation for labor productivity and health management index value, and information processing system therefor
JP6626171B1 (en) * 2018-09-11 2019-12-25 株式会社FiNC Technologies Health assessment system and health assessment program

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045523A (en) * 1983-08-11 1985-03-12 Kureha Chem Ind Co Ltd Central nervous system depressant

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017068831A (en) * 2015-09-30 2017-04-06 日通システム株式会社 Labor management system, labor management method and labor management program
JP2017170066A (en) * 2016-03-25 2017-09-28 東芝情報システム株式会社 Health management system and health management program
JP2019185416A (en) * 2018-04-11 2019-10-24 アビームコンサルティング株式会社 Automatic calculation for labor productivity and health management index value, and information processing system therefor
JP6626171B1 (en) * 2018-09-11 2019-12-25 株式会社FiNC Technologies Health assessment system and health assessment program
KR20190104500A (en) * 2019-09-02 2019-09-10 차의과학대학교 산학협력단 Disease Network Generating Method using Cohort and Computer Readable Record Medium thereof

Also Published As

Publication number Publication date
KR102320132B1 (en) 2021-11-01
KR20210092586A (en) 2021-07-26

Similar Documents

Publication Publication Date Title
WO2020022639A1 (en) Deep learning-based evaluation method and apparatus
WO2017014469A1 (en) Disease risk prediction method, and device for performing same
WO2020078058A1 (en) Medical data abnormality identification method and device, terminal, and storage medium
WO2021145740A1 (en) Group health index evaluation method and computer program for executing same
WO2018199658A1 (en) Method for asset management of electric power equipment
WO2021101069A1 (en) Apparatus and method for testing semiconductor device by using machine learning model
WO2019107804A1 (en) Method for predicting drug-drug or drug-food interaction by using structural information of drug
WO2021012481A1 (en) System performance monitoring method and apparatus, device, and storage medium
WO2023033329A1 (en) Device and method for generating risk gene mutation information for each disease through disease-related gene mutation analysis
WO2021070983A1 (en) Vr training system and method
WO2020168606A1 (en) Advertisement video optimising method, apparatus and device and computer readable storage medium
WO2018129960A1 (en) Screen flickering processing method, device, storage medium, and electronic device
WO2021145722A1 (en) System and method for predicting stock and product investment price by using auxiliary indicator
WO2022019500A1 (en) Method for providing compensated practical training for participants in practical training for crowdsourcing-based project for generating artificial intelligence learning data, device therefor, and computer program therefor
WO2021210838A1 (en) Method and system for predicting biological age on basis of various omics data analyses
WO2018008835A1 (en) Risk management method for securities portfolio and risk management device therefor
WO2020122546A1 (en) Method for diagnosing and predicting science/technology capacity of nations and corporations by using data regarding patents and theses
WO2021125479A1 (en) Hair loss management device and hair loss management guideline providing method therefor
WO2024005330A1 (en) Artificial intelligence-based method, apparatus, and system for providing work engagement state determination and management service
WO2023058920A1 (en) Method and apparatus for recommending position based on user's tendencies for human resource management
WO2021020717A1 (en) Device and method for providing stock price information
WO2011068315A2 (en) Apparatus for selecting optimum database using maximal concept-strength recognition technique and method thereof
WO2022010168A1 (en) Method for predicting risk of dementia in parkinson's disease patient and device for predicting risk of dementia
WO2023063528A1 (en) Device and method for generating disease onset information by means of disease-related factor analysis based on time variability
WO2023195579A1 (en) Server and method for providing recommended investment item on basis of investment portfolio of investor

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21740687

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21740687

Country of ref document: EP

Kind code of ref document: A1